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 Lamin A is a major component of the lamina, which creates a dynamic 
network underneath the nuclear envelope. Mutations in the lamin A gene (LMNA) 
cause severe genetic disorders. One of the most striking cases is Hutchinson-Gilford 
progeria syndrome (HGPS). It is caused by a lamin A mutant protein named progerin. 
Due to the abnormal retaining of a permanent C-terminal farnesyl tail, progerin 
gradually accumulates on the nuclear membrane, resulting in abnormal nuclear 
morphology during interphase and perturbing a diversity of signaling and 
transcriptional events. To better understand lamin A gene’s function and regulation, I 
studied lamin A from three aspects in my dissertation, including its post-translational 
processing, post-transcriptional degradation, and transcriptional regulation. For post-
translational processing, I examined the potential effects of cytoplasmic progerin 
based on a previous observation that membrane-associated progerin forms visible 
cytoplasmic aggregates in mitosis. After removal of the nuclear localization signal, I 
find that both LAΔNLS and PGΔNLS mutants are farnesylated in the cytosol and 
  
associated with a sub-domain of the ER via their farnesyl tails. While the 
farnesylation on LAΔNLS can be gradually removed by Zempste24, PGΔNLS 
remains permanently farnesylated and aggregated in the cytosol. Moreover, both 
ΔNLS mutants dominantly affect emerin’s nuclear localization. Previously, the 
accumulation of progerin has led to the speculation that progerin is more stable than 
the wild type lamin A. However, the low solubility of lamin proteins renders 
traditional immunoprecipitation-dependent methods ineffective for comparing the 
relative stabilities of mutant and wild type lamins. Therefore, to investigate the post-
translational degradation of lamin A, I employed a novel platform based on viral 2A 
peptide-mediated co-translational cleavage to infer differences in lamin stability. My 
results support the notion that progerin is more stable than lamin A. In addition, 
treatment of FTI reduces progerin relative stability to the level of wild type lamin A. 
Last but not the least, I investigated the function of LMNA first intron in order to 
better understand the transcription regulation of lamin A. My results show that a 
highly conserved region within LMNA first intron is essential for the expression 
repression of lamin A in HL60 cells. This process is fulfilled by the interaction 
between this conserved region and transcription factor Sp1. Taken together, my 
results reveal new insights into biogenesis, protein interaction and transcription 




























Dissertation submitted to the Faculty of the Graduate School of the  
University of Maryland, College Park, in partial fulfillment 
of the requirements for the degree of 













Professor   Kan Cao, Chair 
Professor   Sridhar Hannenhalli 
Professor   Zhongchi Liu  
Professor   Leslie Pick 


















































This dissertation is dedicated to my family, 
my Mom, my Dad, my husband and my son, 
for their unconditional love, understanding, support and encouragement. 
Especially to my grandma, 






This dissertation would not have been accomplished without my advisor, Dr. 
Kan Cao. I would like to thank her for providing me the opportunity to join her lab 
and start my projects as well as her continuous encouragement, inspiration, patience, 
understanding and support during my entire dissertation work. Importantly, she set a 
great example of a strong independent woman that will benefit me for the rest of my 
life. 
I would also like to express my gratitude to my committee members, Dr. 
Leslie Pick, Dr. Sridhar Hannenhalli, Dr. Zhongchi Liu, Dr. Sougata Roy and recently 
retired Dr. Stephen Wolniak, for always making time to attend my committee 
meetings and giving me helpful suggestions and feedbacks on my projects. 
I would like to acknowledge our collaborators Dr. Philip Yates and Dr. 
Andrew Flannery for their contribution of providing essential experimental materials 
and critical ideas to my research.  
In addition I thank the fine technique support of Amy Beaven from the 
imaging core and Kenneth Class from the flow cytometry core of the Core Laboratory 
Facilities of the Department of Cell Biology and Molecular Genetics at the University 
of Maryland. 
Last, I am the most grateful to all the members that I have been working with 
in the Cao Lab. They are Dr. Zhengmei Xiong, Dr. Linlin Sun, Dr. Pratima Bharti, 
Dr. Haoyue Zhang, Kun Wang, Julie Choi, Xiaojing Mao, Yantenew Gedle Gete, 




Natasha Ivanina, Helen Cai and Jason Albanese. Thank all of you for your help, 








Table of Contents .......................................................................................................... v	
List of Figures .............................................................................................................. ix	
List of Abbreviations ................................................................................................... xii	
Publication information ............................................................................................... xv	
Chapter 1: Introduction ................................................................................................. 1	
1.1 The nuclear lamina and lamins ............................................................................ 2	
1.1.1 Nuclear lamina composition and organization ............................................. 2	
1.1.2 Lamin proteins structural features and assembly ......................................... 3	
1.1.3 Lamin proteins processing and maturation .................................................. 5	
1.1.4 Functional roles of nuclear lamins ............................................................... 6	
1.2 Hutchinson–Gilford progeria syndrome (HGPS) .............................................. 10	
1.2.1 Laminopathies ............................................................................................ 10	
1.2.2 HGPS .......................................................................................................... 12	
1.3 Regulation of lamin A expression ..................................................................... 20	
1.3.1 Transcriptional regulation .......................................................................... 20	
1.3.2 Post-transcriptional regulation ................................................................... 23	
1.3.3 Protein turnover and stability ..................................................................... 25	




Chapter 2: Nuclear localization signal deletion mutants of lamin A and progerin 
reveal insights into lamin A processing and emerin targeting .................................... 30	
2.1 Introduction ....................................................................................................... 31	
2.2 Results ............................................................................................................... 34	
2.2.1 Deletion of NLS directs lamin A and progerin to the ER .......................... 34	
2.2.2 The C-terminal farnesyl group tethers LAΔNLS and PGΔNLS to the ER 
membrane ............................................................................................................ 38	
2.2.3 Nuclear targeting of emerin is disrupted by LAΔNLS and PGΔNLS ........ 41	
2.3 Discussion ......................................................................................................... 43	
2.3.1 The processing of prelamin A by the INM and ER localized ZMPSTE24 43	
2.3.2 Emerin nuclear localization is disrupted by PGΔNLS ............................... 45	
Chapter 3: Comparing lamin proteins post-translational relative stability using a 2A 
peptide-based system reveals elevated resistance of progerin to cellular degradation 47	
3.1 Introduction ....................................................................................................... 48	
3.2 Results ............................................................................................................... 52	
3.2.1 Progerin possesses higher post-translational stability than lamin A protein 
in primary fibroblasts and human bone marrow-derived mesenchymal stem cells 
(hBM-MSCs). ...................................................................................................... 52	
3.2.2 Endogenous lamin A may not alter the post-translational stability of 
exogenously expressed A type lamin proteins .................................................... 56	
3.2.3 FTI treatment reduces progerin stability in fibroblasts .............................. 58	




Chapter 4: LMNA first intron mediates transcription suppression through Sp1 binding
 ..................................................................................................................................... 65	
4.1 Introduction ....................................................................................................... 66	
4.2 Results ............................................................................................................... 68	
4.2.1 Conserved regions with potential transcriptional regulatory activities are 
identified in the LMNA first intron ...................................................................... 68	
4.2.2 Sp1, together with its co-factors E2F1 and HDAC2, are predicted to be the 
potential regulatory element binding to Con 5 in the lamin A first intron .......... 71	
4.2.3 Sp1, E2F1 and HDAC2 expression levels are inversely associated with the 
lamin A amounts in HL60 and fibroblasts .......................................................... 73	
4.2.4 Repressive effects of SP1 on lamin A expression depends on its binding to 
Con5 in LMNA first intron .................................................................................. 75	
4.3 Discussion ......................................................................................................... 77	
Chapter 5:  Summarization and future directions ........................................................ 79	
5.1 Summarization .................................................................................................. 80	
5.2 Future directions ................................................................................................ 83	
Chapter 6:  Materials and methods .............................................................................. 86	
6.1 Plasmid construction ......................................................................................... 87	
6.2 Cell culture and FTI treatment .......................................................................... 89	
6.3 Plasmid and siRNA transfection ....................................................................... 90	
6.4 Virus generation and viral infection .................................................................. 91	
6.5 Antibodies ......................................................................................................... 91	




6.7 Immunofluorescence staining and microscopy ................................................. 92	
6.8 Immunoprecipitation ......................................................................................... 93	
6.9 Click chemistry assay ........................................................................................ 94	
6.10 Fluorescence recovery after photobleaching (FRAP) assay ........................... 94	
6.11 RNA extraction, cDNA synthesis, and quantitative RT–PCR ........................ 94	
6.12 Chromatin immunoprecipitation (ChIP) ......................................................... 95	
6.13 Luciferase activity assay ................................................................................. 96	
6.14 Conserved region identification and putative transcription factor binding 





List of Figures 
 
Chapter 1: Introduction 
Figure 1-1. Structure of A- and B-type lamins…………………………..……….…...3 
Figure 1-2. Assembly of lamins into intermediate filaments……………………….…4 
Figure 1-3. Processing of A- and B-type lamins…………………………………...….6 
Figure 1-4. A Dutch HGPS patient at the age of 1, 2, 6, 7, 8, 10, and 12 years…..…13 
Figure 1-5. Activation of a cryptic splice donor site in exon 11 of LMNA gene of 
HGPS mutation…………………………………………………………………...….14 
Figure 1-6. Lamin A–processing defects in HGPS…………………….………….…16 
Figure 1-7. Two opposing models for the intracellular location of prelamin A 
processing…………………………………………………………………………....24 
 
Chapter 2: Nuclear localization signal deletion mutants of lamin A and progerin 
reveal insights into lamin A processing and emerin targeting 
Figure 2-1. Sequences and positions of the primers used for generation of the NLS 
mutants………………………………………………………………………..……...34 
Figure 2-2. Characterization of the NLS-deleted lamin A and progerin…………….35 
Figure 2-3. The time course experiment showing the localization changes of NLS-
deleted mutants……………………………………………………………………....36 
Figure 2-4. ER localization of NLS-deleted mutants………………………………...37 
Figure 2-5. Fluorescence Recovery After Photo bleaching (FRAP) analysis of 




Figure 2-6. C-terminal farnesyl group tethers LAΔNLS and PGΔNLS to the ER 
membrane………………………………………………………………………….....39 
Figure 2-7. The effect of FTI treatment resembles that of LAssimΔNLS…………...40 
Figure 2-8. Disrupted emerin localization in cells expressing LAΔNLS or 
PGΔNLS……………………………………………………………………………..42 
 
Chapter 3: Comparing lamin proteins post-translational relative stability using a 
2A peptide-based system reveals elevated resistance of progerin to cellular 
degradation 
Figure 3-1. Schematic diagrams of processing and creation of 2A constructs……....50 
Figure 3-2. Characterization of 2A constructs in both human fibroblasts and hBM-
MSCs………………………………………………………………………………...53 
Figure 3-3. Full gel image of fibroblasts expressing Rluc-P2A-EGFP-lamin A (P-
LA), Rluc-P2A-EGFP-progerin (P-PG) and Rluc-P2A-EGFP-lamin B1 (P-LB1)….54 
Figure 3-4. Comparing relative stability of lamin A, progerin and lamin B1 in 
fibroblasts and hBM-MSCs……………………………………………………….....55 
Figure 3-5. Examining lamin relative stabilities in both LAC/C and LA-/- MEFs….57 
Figure 3-6. Effects of FTI on lamins relative stabilities in human fibroblasts……....59 
Figure 3-7. Representative confocal images of FTI treated fibroblasts for 4 days. 
Green indicates EGFP signals………………………………………………………..59 
Figure 3-8. Effects of FTI on relative protein abundance of endogenous lamin B1 and 





Chapter 4: LMNA first intron mediated transcription suppression of lamin A 
through Sp1 binding 
Figure 4-1. Screen shot of LMNA gene structure information from UCSC genome 
browser……………………………………………………………………………….69 
Figure 4-2. Functional analysis of LMNA first intron…………………………….....70 
Figure 4-3. Reciprocal expression pattern between endogenous lamin A and the 
protein candidates Sp1, E2F1 and HDAC2……………………………………….....72 
Figure 4-4. siRNA knocking down of SP1, E2F1, HDAC2 induces lamin A 
transcription in HL60………………………………………………………………...74 
Figure 4-5. Overexpression of SP1, E2F1, HDAC2 decrease lamin A transcription in 
fibroblasts…………………………………………………………………………….75 




List of Abbreviations 
 
 
BAF: barrier- to-autointegration factor 
CDK1: cyclin-dependent kinase 1 
CSIM: cysteine-serine-isoleucine-methionine 
ChIP: chromatin immunoprecipitation 
Con1: conserved region 1 
CRNSP: Ca+2-regulated nuclear scaffold protease 
DHS: DNase I hypersensitive site 
DSB: double strand breaks 
ER: endoplasmic reticulum 
ESC: embryonic stem cell 
FMDV: mouth disease virus 
FTase: farnesyltransferase 
FTI: farnesyltransferase inhibitor 
GCL: germ-cell-less 
hBM-MSCs: human bone marrow-derived mesenchymal stem cells 
hESC: human embryonic stem cell 
HDAC2: histone deacetylase 2 
HGPS: Hutchinson-Gilford progeria syndrome 
HEK293T: Human embryonic kidney cells 293T 
HP1α: heterochromatin protein 1 α 




H3K9me3: histone H3 lysine 9 trimethylation  
H3K27me3: histone H3 lysine 27 trimethylation 
H4K20me3: histone H4 lysine 20 trimethylation 
Icmt: isoprenylcysteine carboxyl methyltransferase 
IF: intermediate filament 
INM: inner nuclear membrane 
LA: lamin A 
LADs: lamin-A-associated domains 
LAP2: lamina-associated polypeptide 2 
LBR: Lamin B receptor 
LB1: lamin B1 
L-RARE: retinoic acid responsive element 
MAD: mandibuloacral dysplasia 
MEF: mouse embryonic fibroblasts 
mTOR: mechanistic target of rapamycin 
NAC: N-acetyl cysteine 
NE: nuclear envelope 
NLS: nuclear localization sequence 
ORF: open reading frame 
PG: progerin 
pol II: RNA polymerase II 
P2A: 2A sequence from Porcine teschovirus-1 





Rce1: Ras-converting enzyme 1 
RD: restricted dermopathy 
Rluc: Renilla luciferase 
ROCK: Rho-associated protein kinase 
ROS: reactive oxygen species 
RXRβ: retinoic X receptor β 
SFFV: spleen focus-forming virus 
SREBP1: sterol response element binding protein 1 
SSIM: serine-serine-isoleucine-methionine 
TFs: transcription factors 
TSS: transcription start site 
UTR: untranslated region 
WS: Werner’s syndrome 
Zmpste24: Zinc metalloprotease related to Ste24p 







The data from this thesis composed the following publications. 
 
Wu D, Flannery AR, Cai H, Ko E, Cao K. Nuclear localization signal deletion 
mutants of lamin A and progerin reveal insights into lamin A processing and emerin 
targeting. Nucleus. 2014 Jan-Feb;5(1):66-74. 
 
Wu D, Yates PA, Zhang H, Cao K. Comparing lamin proteins post-translational 
relative stability using a 2A peptide-based system reveals elevated resistance of 


















1.1 The nuclear lamina and lamins 
1.1.1 Nuclear lamina composition and organization 
 In eukaryotic cells, there is a dense (~30 to 100 nm thick) fibrillar network 
structure lying underneath the nuclear envelope (NE), named nuclear lamina. It is 
composed of intermediate filaments (IF) and membrane associated proteins, and 
located at the interface between chromatin and the inner nuclear membrane (Fawcett, 
1966; Goldman et al., 2002; Rodgers et al., 1995). Besides providing mechanical 
support to the nucleus in the cell, nuclear lamina participates in important cellular 
processes including DNA replication, chromatin remodeling and so on (Bridger et al., 
2007; Goldman et al., 2002; Gruenbaum and Foisner, 2014; Gruenbaum et al., 2005; 
Spann et al., 2002).  
 In metazoan cells, the major components of the nuclear lamina are A and B 
type lamins, which are type V intermediate filaments and differ in their structural and 
protein features and expression patterns (Dittmer and Misteli, 2011). There are three 
different genes responsible for at least seven lamin protein isoforms’ expression in 
mammalian cells (Dittmer and Misteli, 2011). The A type lamins include lamin A, 
AΔ10, C, and C2 variants. They are generated from the LMNA gene on 1q21 by 
alternative splicing and only expressed upon differentiation (Furukawa et al., 1994; 
Krohne et al., 2005; Machiels et al., 1996; McKeon et al., 1986). Lamin A and C are 
the major isoforms. They share the same first 566 amino acids, but lamin C lack 98 
amino acids at the carboxyl terminus and the CaaX box which are present in prelamin 




unique six amino acid carboxyl terminus (Dittmer and Misteli, 2011). B-type lamins 
are constitutively expressed in both undifferentiated and differentiated cell. Three B 
type lamins are encoded from two separate genes: lamin B1 is encoded by LMNB1 on 
5q23, while lamin B2 and B3 are isoforms derived from LMNB2 on 19q13 (Furukawa 
and Hotta, 1993; Krohne et al., 2005; Pollard et al., 1990). Both lamin C2 and B3 are 
germ cell specific. 
1.1.2 Lamin proteins structural features and assembly 
 As members of IF family, nuclear lamins possess similar protein structures as 
cytoplasmic intermediate filaments. They contain a central a-helical rod domain 
flanked by a globular amino-terminal head domain and a carboxy-terminal tail 
domain (Fig 1-1) (Burke and Stewart, 2012; Stuurman et al., 1998). The central rod 
domain comprises four coiled-coil domains separated by flexible linker regions. The  
 
 
Figure 1-1. The structure of A- and B-type lamins. (A) Each of the lamins features a small (10–20 
residues) 'head' domain followed by a central rod domain containing four coiled-coil regions (termed 
1A, 1B, 2A and 2B). The large non-helical 'tail' domain is organized around an immunoglobulin (Ig)-
like β-fold. A nuclear localization sequence (NLS) lies immediately downstream of the rod domain. 
Proteolytic cleavage of pre-lamin A (indicated by a black arrowhead) results in the appearance of 
mature lamin A. Lamin A and each of the B-type lamins contain a carboxy-terminal CaaX motif 
(where C is Cys, a is an aliphatic residue and X is usually represented by a Met) that defines a site of 




high order structure of lamin filaments is initially organized through the dimerization 
of central rod domains. Two lamin proteins first coil around each other parallelly to 
forming a lamin dimer. This is the basic building block of lamin assembly. Lamin 
dimers organize in a head-to-tail manner, generating lamin polymers, which then 
form protofilaments through anti-parallel association. Lamin filaments are eventually 
formed between three and four protofilaments in a diameter around 10nm (Fig 1-2) 
(Eriksson et al., 2009; Ho and Lammerding, 2012). Comparing to cytoplasmic IF, the 
lamins tend to carry a shorter amino-terminal head domain despite the size variations 
(Dittmer and Misteli, 2011). The carboxy-terminal tail domain of lamin proteins 
harbors a nuclear localization signal (NLS), an Ig domain and, in most cases, a CaaX 
box (Fig 1-1). The Ig domain mediates diverse protein-protein and protein-ligand 
interactions (Krimm et al., 2002; Shumaker et al., 2005). The CaaX box at the c-
terminus is a target for isoprenylation and carboxymethylation. It contains a cysteine 
(C), followed by two of any aliphatic amino acids (a), and a forth amino acid 
 
 
Figure 1-2. Assembly of lamins into intermediate filaments. Dimerization of lamins is driven by the 
coiled-coil formation of their central rod. Lamin dimers then assemble head to tail into polar polymers, 
which requires an overlapping interaction between the head and tail domains. These polymers then 





that determines the kind of modification (X) (Fig 1-1). For example, CaaX box for 
mammalian lamin A and B1 is CSIM and CAIM respectively, therefore 
farnesyltransferase recognizes the box and mediates farnesylation for these lamin 
proteins (Dechat et al., 2010; Eriksson et al., 2009; Stuurman et al., 1998). 
1.1.3 Lamin proteins processing and maturation 
 As mentioned earlier, lamin A and B type lamins contain a CaaX box at their 
C-terminus. Proper processing of the CaaX box is critical for the membrane 
association, localization and function of lamin proteins (Capell et al., 2005; Gelb et 
al., 2006; Yang et al., 2005). Lamin precursors undergo extensive post-translational 
modifications on the CaaX box to become mature lamin proteins (Fig 1-3) (Burke and 
Stewart, 2012; Rusiñol and Sinensky, 2006; Yang et al., 2005). In the first step, a 
farnesyl group is attached to the cysteine of the CaaX box by a farnesyltransferase 
(FTase), followed by the removal of the aaX residues by Rce1 (Ras-converting 
enzyme 1) and/or Zmpste24 (Zinc metalloprotease related to Ste24p)/FACE 1 
(Rusiñol and Sinensky, 2006). Next, the farnesylated cysteine is carboxymethylated 
by isoprenylcysteine carboxyl methyltransferase (Icmt). At this step, the process of B 
type lamins maturation is terminated. Therefore, B type lamins such as lamin B1 and 
B2 permanently retain the farnesylated and carboxymethylated C-terminus (Dechat et 
al., 2010). Whereas there is one last step to be completed that is crucial for lamin A 
maturation. In the final step, the last 15 amino acids of prelamin A including the 
farnesylated C-terminus are further excised by Zmpste24 to allow the release of 




It is notable that lamin C (a splice variant of the LMNA gene) lacks a CaaX box and is 
not modified at all. 
 
1.1.4 Functional roles of nuclear lamins 
 Grouped into IF superfamily, nuclear lamins were originally thought to be the 
structural proteins that provide mechanical support to the nucleus, maintaining 
nuclear morphology and resisting to chromatin deformation (Hutchison, 2002). In 
support of this idea, depletion of lamins resulted in small and fragile nuclei in 
Xenopus nuclear assembly systems (Ellis et al., 1997; Meier et al., 1991; Newport et 
 
 
Figure 1-3. Processing of A- and B-type lamins. Farnesylation of lamins on the CaaX Cys residue by a 
protein farnesyltransferase occurs soon after synthesis. This is followed by proteolysis of the aaX 
residues by farnesylated proteins-converting enzyme 2 (FACE2; also known as CaaX prenyl protease) 
in the case of the B-type lamins, and by ZMPSTE24, a zinc metallo-endoprotease, in the case of lamin 
A. Processing of the CaaX motif is completed by carboxyl methylation by ICMT (isoprenylcysteine 
carboxymethyltransferase) of the new C terminus. Once incorporated into the nuclear lamina, lamin 
A, but not the B-type lamins, undergoes an additional ZMPSTE24-mediated cleavage step (in human 
lamin A this occurs after Tyr646, black arrowhead in a), which removes an additional 15 amino acids, 
including the farnesylated Cys, leading to the appearance of non-farnesylated mature lamin A (Burke 




al., 1990; Spann et al., 1997). In addition, fibroblasts from Lmna-/- mice showed that 
the nuclei are more easily to be deformed and less resistant to physical compression 
comparing to Lmna+/+ littermates (Lammerding et al., 2004). However, with 
intensive research carried out on lamins, more of their cellular functions have been 
revealed. They are not limited to mechanical support but entangled with a wild range 
of cellular regulations, including chromatin organization, DNA replication, 
transcription, differentiation and development etc. (Bridger et al., 2007; Goldman et 
al., 2002; Gruenbaum and Foisner, 2014; Spann et al., 2002). 
 1.1.4.1 Chromatin organization  
 Lamins globally regulate chromatin organization. Nuclear lamina tends to 
associate with transcriptionally silent regions of the genome, such as centromeres, 
telomeres and the inactive X chromosome (Belmont et al., 1993; Fawcett, 1966; 
Guelen et al., 2008). The highly organized heterochromatin is localized to the 
periphery of the nucleus, closely associated with the lamina (Dechat et al., 2008). 
However, not all the chromatin regions associated with lamina are repressed. 
Previously, it has been reported that a genetic locus, which has been targeted to the 
nuclear periphery by lamin B1, maintains its ability to be transcribed (Kumaran and 
Spector, 2008). In general, the lamina is more associated with inactively transcribed 
chromosome territories, such as gene-poor human chromosome 18, on the contrary, 
gene-rich chromosome 19 resides preferentially deep inside the nucleus (Croft et al., 
1999). Perturbation of lamins, such as lamin A, leads to loss of peripheral 
heterochromatin, ectopic chromosome condensation and mis-positioning of 




al., 1999). Meanwhile, global epigenetic histone markers are also altered, including 
decreased levels of the heterochromatin markers histone H3 lysine 9 trimethylation 
(H3K9me3) and H3K27me3 and increased levels of H4K20me3 (Dittmer and Misteli, 
2011). Genome-wide mapping techniques have identified genome regions that 
preferentially associate with lamins, known as lamin-A-associated domains (LADs). 
These domains are generally gene-poor and are proposed to represent a repressive 
chromatin environment (Guelen et al., 2008). 
 1.1.4.2 Transcription and gene expression 
 Both A and B type lamins have been reported to involve in transcription gene 
expression regulation. In Xenopus laevis oocytes, RNA polymerase II (pol II) activity 
was inhibited by overexpression of N-terminally deleted lamins, accompanied by the 
disassembly of the endogenous lamin network, leading to an impairment of 
transcription (Gruenbaum et al., 2005; Spann et al., 2002). There are examples 
indicate the transcription and gene expression regulation of lamins are facilitated by 
transcription factors and lamin-associated proteins, such as LAP2 and emerin both of 
which belong to LEM-domain proteins (Lin et al., 2000). LAP2β, an INM residing 
lamin interacting proteins binds exclusively to lamin B (Foisner ’ and Gerace, 1993), 
forms functional complexes with B-type lamins as well as the transcription factors 
germ-cell-less (GCL) and E2f-associated protein (DP) to inhibit E2F activity (Nili et 
al., 2001). Another member of LAP2 family, LAP2α, that interacts specifically to A-
type lamins, associates with lamin A/C in a complex with retinoblastoma (Rb) that 




Whereas mutant forms of Rb that cannot be tethered promote cancer through E2F 
mediated cell-cycle progression, suggesting the necessary of Rb nuclear tethering for 
its stability and function (Hinds et al., 1992). Actually, a large number of lamin A 
binding proteins are transcriptional factors, such as zinc finger protein MOK2 
(Dreuillet et al., 2002) and sterol response element binding protein 1 (SREBP1) 
(Lloyd et al., 2002), which contribute to the transcription regulation role of lamin 
proteins. The INM protein emerin has been suggested to form at least two distinct 
lamin-anchored complexes by binding to GCL and barrier to autointegration factor 
(BAF) (Bengtsson and Wilson, 2004; Holaska et al., 2002). Moreover, the GCL-
binding region in emerin can also bind to other gene regulators, such as BCL2-
associated transcription factor (BTF) known a death-promoting repressor, implicating 
a role of emerin–lamin complexes in transcriptional regulation (Haraguchi et al., 
2004). 
 1.1.4.3 Development and differentiation 
 It is well known that A- and B-type lamins are expression at different 
developmental stages (Gruenbaum et al., 2005; Stuurman et al., 1998). B-type lamins 
can be detected throughout the entire development. Whereas A-type lamins are 
undetectable until a later stage when differentiation initiates (Broers et al., 1997). The 
changes in lamin expression have been reported crossing species in early 
development of Xenopus (Benavente et al., 1985; Lourim et al., 1996; Stick and 
Hausen, 1985; Wolin et al., 1987), Drosophila (Riemer et al., 1995), chicken (Lehner 
et al., 1987) and mouse embryos (Röber et al., 1989; Stewart and Burke, 1987). It has 




embryonic stem (ES) cells is responsible for the high deformability of the nuclei in 
these cells (Pajerowski et al., 2007). Depending on the site of the mutation, mutants 
of Dm0, the B-type Drosophila lamin, cause lethality at different embryonic or late 
pupal stages (Gruenbaum et al., 2003; Osouda et al., 2005). Furthermore, Vergnes et 
al. have shown that lamin B1 deficient mice die at birth with defective lungs and 
bones (Vergnes et al., 2004). On the other hand, lamin A/C deficient animals develop 
normally until birth, but have severe postnatal growth retardation and develop 
muscular dystrophy (Sullivan et al., 1999). All these evidences suggested that lamins 
are closely correlated with cell differentiation and development. In support, evidence 
has been shown that A-type lamins are highly involved with differentiation of many 
cell linages, including adipocytes, osteoblasts and adult stem cells. Lamins A/C 
regulate adipocyte differentiation together with the INM protein emerin through 
influencing the distribution of β-catenin in nucleocytoplasm (Tilgner et al., 2009). In 
addition, silencing lamins A/C expression causes impaired osteoblastogenesis and 
accelerated osteoclastogenesis in human bone marrow stromal cells (Akter et al., 
2009; Rauner et al., 2009). Moreover, a dominant negative lamin A mutant, progerin, 
impairs the differential potential of human mesenchymal stem cells, probably by 
affecting the Notch-signaling pathway (Espada et al., 2008). 
1.2 Hutchinson–Gilford progeria syndrome (HGPS) 
 1.2.1 Laminopathies 
 Since the first discovery of LMNA mutations cause autosomal dominant 




number of mutations in nuclear lamins, have successively been found to link with 
around 20 genetic disease (Dittmer and Misteli, 2011), collectively known as the 
laminopathies. Noteworthy, both the number of lamin mutations and associated 
diseases is continuing to grow. The majority of these diseases is heterozygous and at 
lease 17 (Dittmer and Misteli, 2011) of them are associated with more than 300 
different mutations in LMNA producing around 200 mutant lamin A/C proteins 
(Dechat et al., 2008), existing in the forms of cardiomyopathy, muscular dystrophy, 
lipodystrophy and aging related progeria. The latter includes Hutchinson-Gilford 
progeria syndrome (HGPS), atypical Werner’s syndrome (WS), restricted dermopathy 
(RD), and mandibuloacral dysplasia (MAD) (Broers et al., 2006; Kudlow et al., 2007; 
Worman and Bonne, 2007), suggesting a closely associated role of lamin A with 
human aging.  
 Contrary to LMNA, only two diseases are reported to be associated with 
mutations in the LMNB1 and LMNB2 genes, which is probably due to the ubiquitous 
expression and the importance for viability of B-type lamin. These include 
autosomal-dominant leukodystrophy caused by a duplication of LMNB1 that resulting 
in higher LMNB1 dosage/expression in brain tissues and acquired partial 
lipodystrophy caused by several rare LMNB2 missense mutations (Hegele et al., 
2006; Padiath et al., 2006). 
 Yet, how different mutations on the single LMNA gene affect its function and 
lead to a wild range of tissue specific diseases in the laminopathies still remain 
ambiguous. More investigations towards lamin A/C function and regulation are 




 1.2.2 HGPS 
 Among all the known laminopathies, HGPS manifests the most striking 
accelerated aging symptoms. The reported incidence of this disorder is 1 in 8 million, 
but could be as high as 1 in 4 million, which takes into consideration of unreported or 
misdiagnosed cases (Capell and Collins, 2006; Sarkar and Shinton, 2001). As of 
December 2016, there are 111 known HGPS cases worldwide 
(www.progeriaresearch.org), approximately forty of which are current (Pollex and 
Hegele, 2004). HGPS affects both genders. The patients tend not to live beyond their 
teenage years, with the cause of death predominantly due to atherosclerosis at an 
average age of 13 (Capell and Collins, 2006; Merideth et al., 2008).  
 1.2.2.1 Clinical manifestations 
 Children with HGPS typically appear normal at birth, but then they experience 
severe failure to thrive and gradually show symptoms of accelerated aging during the 
first year of life (Fig 1-4). After the age of 3, these children almost always exhibit 
delayed growth, short stature, and below-average weight comparing to their healthy 
peers. HGPS patients also display typical facial features such as a small jaw, 
prominent eyes, hair loss, craniofacial disproportion, delayed and crowded dentition, 
and prominent scalp veins. In addition, due to the lost of subcutaneous fat, their skin 
shows wrinkled and aged appearance. Other abnormalities include a thin, high-
pitched voice, a pear-shaped thorax, a “horse-riding” stance, and stiff joints. The most 
devastatingly, this disease impairs the patient’s cardiovascular system, causing 




However, Children with HGPS experience normal motor and mental development 
(Merideth et al., 2008; Pollex and Hegele, 2004). 
 1.2.2.2 Genetic cause 
 Progeria was first described by Jonathan Hutchinson and Hastings Gilford in 
1886 and 1904, respectively, whose names were later give rise to the name of the 
disease - Hutchinson–Gilford progeria syndrome. Although it was documented 130 
years ago, the molecular mechanism that causes HGPS was not unraveled until 2003 
(Eriksson et al., 2003). At first, scientists hypothesized it might be a autosomal 
recessive disease based on the observed inheritance pattern that the parents of 
 
 





progeria children were mostly healthy (Khalifa, 1989; Maciel et al., 1988). However, 
a whole-genome scan showed no evidence of homozygosity. Finally by using 
microsatellite genotyping, Eriksson and her colleagues narrowed down the HGPS-
inducing gene to a region of 4.82Mb on proximal chromosome 1q, where roughly 80 
known genes reside. One of the genes, LMNA, immediately drew their attention 
because its mutation were already known to associated with several genetic disorders 
in the form of cardiomyopathy, lipodystrophy, muscular dystrophy, tooth disorder, 
and mandibuloacral dysplasia, which are all observed in patients with HGPS.  
 Eventually, a signal nucleotide substitution from C to T at position 1824 on 
LMNA gene was identified in 18 out of 23 HGPS patient samples after sequencing. 
None of the patients’ parents carried this mutation, suggesting it’s a de novo point 
mutations. It is a synonymous substitution that does not alter the original amino acid 
sequence (G608G (GGC>GGT)), instead it introduces a cryptic splice donor site 
within exon 11 of LMNA gene, which leads to a in-frame deletion of extra 150 




Figure 1-5. Activation of a cryptic splice donor site in exon 11 of LMNA gene of HGPS mutation. 
The de novo C to T mutation introduces a cryptic splice donor site within exon 11 of LMNA gene, 
which leads to a in-frame deletion of extra 150 nucleotides from exon 11 with mRNA, and eventually 




has 12 exons and generates two protein isoforms, lamin A and lamin C. Lamin A is 
coded by exon 1-12 and lamin C by exon 1-10 (Dittmer and Misteli, 2011). As 
mentioned earlier, lamin A maturation undergoes CaaX modification at the C-
terminus (Burke and Stewart, 2012; Rusiñol and Sinensky, 2006; Yang et al., 2005), 
in which a farnesyl group was first added to the cysteine of the CaaX box (CSIM) of 
lamin A precursor by a farnesyltransferase. Then the aaX group (SIM) is removed by 
Rce1 and/or Zmpste24 endoprotease (Rusiñol and Sinensky, 2006), followed by 
carboxymethylation of the terminal farnesylated cysteine (Dai et al., 1998). In the last 
step, Zmpste24 carries out a second cleavage to remove the terminal 15 amino acids, 
including the farnesyl group (CORRIGAN et al., 2005; Hennekes and Nigg, 1994). 
For HGPS patients, due to the synonymous substitution and the subsequent deletion 
on prelamin A mRNA, a mutant protein product that is 50 amino acids shorter than 
the wild type lamin A, named progerin, is generated. The effective cite of the second 
Zmpste24 cleavage falls right into the deleted 50-amino acid-region, therefore, this 
final cleavage step is blocked in HGPS, and progerin permanently maintain its 
farnesylated C-terminus in patient cells like B-type lamins (D’Apice et al., 2004; De 
Sandre-Giovannoli et al., 2003; Sinensky et al., 1994) (Fig 1-6). However, it is still 
not clear why the substitution happens spontaneously.  
 1.2.2.3 Cellular effects 
 Progerin is expressed in multiple tissues, mostly of mesenchymal origin 
including skin, bone, skeletal muscle, adipose tissue, heart and large and small 
arteries (Gordon et al., 2014a). The permanently farnesylated progerin acts in a 





nuclear envelope, thereby disrupting normal lamina function and eliciting numerous 
nuclear abnormalities in the cells of HGPS patients. These include the hallmark 
phenotype of HGPS - abnormal blebbed nuclei, clustering of nuclear pores, disrupted 
heterochromatin-lamin interactions, accumulation of DNA damage, defective DNA 
damage repair, telomere aberrations and mitochondrial dysfunction as well as 
alterations in downstream signaling and gene transcription, leading to differentiation 
defects and premature cellular senescence (Brunauer and Kennedy, 2015; Cao et al., 
 
 
Figure 1-6. Lamin A–processing defects in HGPS. lamin A maturation undergoes several steps: 
farnesylation of the carboxyl terminus, cleavage of the three carboxyl terminal amino acids, 
carboxymethylation of the farnesylated cysteine and cleavage of the 15 terminal amino acids (red 
cylinder) by the endoprotease Zmpste24/FACE1. In HGPS cells, due to the 50 amino acid inframe 
deletion caused by the de novo mutation, the lamin A precursor loses the cleavage site (yellow line) 
for Zmpste24/FACE1. Therefore, a noncleavable truncated lamin A permanently carrying the 




2007; Eriksson et al., 2003; Goldman et al., 2004; McCord et al., 2013a; Vidak and 
Foisner, 2016; Zhang et al., 2014). In addition, progerin expression leads to decreased 
expression levels of lamin B1, heterochromatin protein 1 α (HP1α) and LAP2α, and 
loss of nucleoplasmic lamins. It has been reported that the A-type and B-type lamin 
segregation are lost in cells expressing progerin. Instead of polymerizing into distinct 
homopolymers, lamin A and B1 from mixed heteropolymers together with progerin, 
which potentially affect the normal function of both proteins (Delbarre et al., 2006). 
Moreover, it is well recognized that progerin inhibits the proliferation rate and 
lifespan of HGPS fibroblasts in culture (Goldman et al., 2004). They are 
hypersensitive to heat stress and exhibit broad epigenetic changes in histone 
methylation patterns that predate any nuclear shape changes (Paradisi et al., 2005; 
Shumaker et al., 2006). 
 1.2.2.4 Therapeutical strategies 
 Since progerin permanent bears the farnesylated C-terminus and aberrantly 
anchors to the NE, causing massive cellular abnormalities in the patient cells (Capell 
and Collins, 2006), many therapeutic strategies were targeting to the posttranslational 
modification stage, specifically, inhibition of the farnesylation process. That includes 
all the strategies that have been evaluated in progeria patients, for example, 
farnesyltransferase inhibitors (FTIs), which is the first compounds that were tested 
(Lo Cicero and Nissan, 2015). FTIs had previously been used as potential anticancer 
drugs and had acceptable side effects in children, which promises the shortest 
timeline from preclinical to clinical testing (Gordon et al., 2014a). FTI treatments 




increased mouse lifespan and amended disease symptoms in progeria mouse models 
(Capell et al., 2008; Fong et al., 2006; Toth et al., 2005). Based on these benefits, a 
clinical trail with FTI lonafarnib for a minimum of 2 years enrolling 25 HGPS 
children was initiated in 2007. Although with certain variations, promising 
improvements were reported in weight gain, vascular stiffness, bone density and 
cardiovascular function in patients (Gordon et al., 2012b).  
In addition to FTIs, statins and aminobisphosphonates that inhibit the 
synthesis of the farnesyl group have also been tested. Varela et al. have shown that 
combination of pravastatin (a statin) and zoledronate (a aminobisphosphonate) 
markedly improves the progeria symptoms in both HGPS fibroblasts and progeria 
mice model (Varela et al., 2008). Comparing to FTI, the combined treatment inhibits 
both farnesylation and geranylgeranylation of progerin and minimizes the possibility 
of alternative prenylation events that allow for prelamin A processing in HGPS 
patients bypassing the effects of FTIs (Varela et al., 2008). In 2009, clinical trials 
with the combination of the FTI lonafarnib, pravastatin, and zoledronic acid have 
been performed in 37 children with HGPS. Many patients showed improved weigh 
gain, reduced vascular stiffness and increased bone mineral density, but no addictive 
cardiovascular benefit with the addition of pravastatin and zoledronic acid comparing 
to lonafarnib monotherapy treatment (Gordon et al., 2012b; Gordon et al., 2014b; 
Gordon et al., 2016). 
 Alternative strategies affecting progerin from different biological angles have 
also been proposed. Rapamycin, a macrolide antibiotic promotes autophagy by 




used as an anticancer drug and an immunosuppressant in transplantation  (Ehninger et 
al., 2014). It was reported to reverse premature senescence and nuclear shape 
abnormalities of HGPS fibroblasts by elevating progerin clearance through autophagy 
(Cao et al., 2011b). In addition, the antioxidant sulforaphane was shown to enhance 
progerin clearance by stimulating autophagic proteasomal activity in HGPS fibroblast 
(Gabriel et al., 2015).  
 Elevated ROS (reactive oxygen species) level has been reported in HGPS 
patient cells and leads to accumulated DNA damage in the cells (Lattanzi et al., 2012; 
Richards et al., 2011; Viteri et al., 2010). Thus, several ROS scavengers aiming to 
alleviate the abnormal ROS level have been tested as a potentially effective treatment 
for HGPS patients. N-acetyl cysteine (NAC) has been demonstrated to reduce the 
levels of un-repairable double strand breaks (DSB) and to improve the proliferative 
rate in HGPS fibroblasts (Richards et al., 2011). Treatment of methylene blue, an 
antioxidant compound known to stimulate mitochondrial function, showed beneficial 
effects in progeria fibroblast culture, including reduced ROS level and nuclear 
blebbings and improved overall mitochondrial health (Xiong et al., 2016). Recently, a 
rho-associated protein kinase (ROCK) inhibitor identified using high-throughput 
screening results in a reduced abnormal nuclear morphology and DNA DSBs along 
with decreased ROS level in the patient cells (Kang et al., 2017). 
 Splicing-directed therapies using morpholino antisense oligonucleotides were 
also conducted. Morpholinos are small modified oligonucleotides that can block 
splicing events by preventing access of the splicing machinery to the splice sites 




in fibroblasts of HGPS patients and HGPS mouse model respectively using 
morphlino oligos specifically binding to the neighboring region of the HGPS 
mutation (Osorio et al., 2011). More recent, retinoids were shown to reverse aging 
characteristic defects in HGPS primary cells, dependent to the retinoid acid receptors 
(RAR) (Kubben et al., 2016). Vitamin D was found to reduce progerin production in 
HGPS cells through vitamin D receptor pathway (Kreienkamp et al., 2014). 
 These approaches reducing progerin toxicity through different biological 
processes provide potential addictive or synergetic benefits of development of 
combination therapies for HGPS treatment. 
 
1.3 Regulation of lamin A expression 
 The expression of lamin A is highly regulated during development and 
differentiation. Lamin A/C is absent from early embryo and from some 
undifferentiated (embryonic stem cells) and cancer cells (eg. leukemias and 
lymphomas) (Broers et al., 1997; Stadelmann et al., 1990). Although numerous 
researches have been implemented to study lamin A’s function especially after the 
discovery of the cause of HGPS in 2003, there is not much information known about 
the regulation of LMNA gene expression during development and differentiation. 
 1.3.1 Transcriptional regulation 
 Regulatory motifs in LMNA promoter The gene structure of human 




Worman, 1993). Analysis of LMNA 5'-proximal promoter region revealed that it does 
not contain typical TATA boxes immediately to the transcription start sites. This is 
sometimes the case for “housekeeping” genes that are not extensively regulated. 
Instead, two atypical TATA-like elements, several GC-rich stretches and a CCAAT 
box were found further upstream (Lin and Worman, 1993; Lin and Worman, 1997). 
They noticed that lamin A/C was present in extracts from all human tissues but 
visibly reduced on the whole brain compared to heart, placenta, lung, liver, skeletal 
muscle, kidney, and pancreas. Furthermore, several leukemias and lymphomas also 
have little or no level of lamin A/C expression. This differential expression of lamin 
A/C in various tissues and cell lines suggested that transcription from the gene 
encoding these two proteins is probably regulated by cell-type-specific factors. 
However, reporter gene assay of lamin A/C proximal promoter region did not show 
transcription activation differences between cells with or without endogenous lamin 
A/C, suggesting lamin A/C proximal promoter is not responsible for the cell-type-
specific expression of lamin A/C (Lin and Worman, 1997). Therefore, some cis 
inhibitory elements may exist in regions outside of the proximal promoter, for 
example LMNA distal 5’ and 3’ regions and the large first intron, and act as a 
powerful promoter in cells that do not contain lamin A/C. 
 Other regulatory regions have been identified in LMNA promoter region. It 
has been reported that retinoic acid can induce lamin A/C expression in mouse 
embryonic carcinoma cells (Lebel et al., 1987). Later, Okumura and colleagues 
identified a retinoic acid responsive element (L-RARE) in the LMNA promoter that is 




addition, there are also other regulatory motifs in the LMNA promoter binding the 
transcription factors Sp1/3, c-Jun, and c-Fos, and the transcriptional coactivator 
CREB-binding protein (Janaki Ramaiah and Parnaik, 2006; Muralikrishna and 
Parnaik, 2001). 
 Due to the well-known mechanism of transcriptional inactivation by promoter 
CpG island hypermethylation in human tumors (Esteller, 2002; Herman and Baylin, 
2003), scientists tested promoter hypermethylation for LMNA in order to find out 
whether it is accountable for lamin A/C inactivation in a few hematologic 
malignancies. Although some of leukemia and lymphoma cell lines showed positive 
results, most of the tested cell lines do not exhibit CpG island methylation in lamin 
A/C promoter, implying that other mechanisms might be involved in lamin A/C 
repression in these cells. 
 Regulatory role of LMNA first intron  The first intron of LMNA is 
approximately 16 kb, taking up more than 60% of the entire LMNA gene. The second 
intron is roughly 2 kb and the rest nine introns are all less than 1 kb in length (Lin and 
Worman, 1993). Considering its unusually large size and possible regulatory motifs 
embedding, the first intron of LMNA was inspected for elements that are responsible 
for the differential expression of lamin A/C. Nakamachi et al. identified a cluster of 
cell-type-specific DNase I hypersensitive sites (DHSs) in a lamin A/C expressing 
mouse cell line, which is located within the 2.9kb of the 5’ of the LMNA first intron. 
This fragment of the HSs lead to an increased transcription level of luciferase reporter 
constructs when stably integrated into the genome of lamin A/C expressing cells 




transcription initiation site of lamin C2, which is a male germ-cell-specific A-type 
lamin generated from LMNA gene (Nakajima and Abe, 1995). Analysis of the 
upstream region of the lamin C2 translation start site revealed binding sites for the 
transcription factors, hepatocyte nuclear factor-3β and retinoic X receptor β (RXRβ) 
(Nakajima and Abe, 1995).  
With the development of high throughput sequencing technology, more data 
sets, including DNase Digital Footprinting (DNase-DGF), DNaseI HS Sequencing 
(DNase-seq) and FAIRE-seq Open Chromatin (FAIRE-seq) etc., towards open 
chromatin regions are available and more potential regulatory regions such as DHS 
sites have been identified on LMNA gene. In addition, TF bindings and many other 
epigenetic marks like histone modifications and DNA methylation have been reported 
for LMNA first intron (refer to Figure 4-1 in chapter 4). All these data provide strong 
scientific supports and a perfect opportunity for us to further dissect the role of LMNA 
first intron in lamin A transcription regulation. 
 1.3.2 Post-transcriptional regulation 
The location where nuclear lamins are processed has been a paradoxical issue 
in the field over 30 years (Fig 1-7). Although CaaX processing occurs at the cytosolic 
face of ER in the cytosol for most proteins with the CaaX box (Gelb et al., 2006; 
Winter-Vann and Casey, 2005), there are evidences suggest that lamin proteins, eg., 
lamin A, are more likely to be modified within the nucleus. For example, Kinetic 
studies suggest that nuclear import proceeds much more rapidly than maturation of 




have showed that the maturation of lamin A was accompanied with the incorporation 
into the nuclear lamina, which is extracted as a Triton X-100-insoluble particulate 
subcellular fraction (Lehner et al., 1986). Moreover, very nascent unprocessed 
prelamin A proteins has been observed to accumulate within nucleoplasm upon 
farnesylation blockage. On reversal of this block, laminA was observed at the nuclear 
rim (Lutz et al., 1992; Sasseville and Raymond, 1995). More importantly, Michaelis 
group has revealed dual ER/INM localization of CaaX-processing enzymes Zmpste24 
and Icmt, supporting the idea of nucleus being a physiological CaaX-processing  
 
 
Figure 1-7. Two opposing models for the intracellular location of prelamin A processing. Left is the 
Cytosol/ER processing model of lamin A, which is supported by knowledge of CaaX enzyme 
localization to the cytosol (FTase) and ER membranes (Rce1, Icmt, Zmpste24). Right is the is Nuclear 
processing model, which has been hypothesized based on lamin A localization, kinetic studies and the 




compartment (Barrowman et al., 2008). Thus, instead of undergoing processing at the 
ER in the cytosol and then being imported into the nucleus, lamin A precursors are 
first translocated into the nucleus under the control of its nuclear localization 
sequence (NLS) followed by CaaXing modification on INM. 
 Additional to the processing localization paradox, post-transcriptional stability 
of lamin A mRNA was also investigated. In 2012, Jung et al. revealed the mechanism 
that contributes to the lamin A/C inactivation in mouse brain tissue. They noticed that 
most cells in the brain express lamin C but lamin A is mostly repressed, suggesting 
the transcription of LMNA gene is not inhibited. After ruling out the possibility of 
alternative splicing, the authors presented a mechanism involving lamin A 3’UTR, in 
which a brain specific microRNA, miR-9, targets to the 3’UTR of lamin A transcripts, 
mediating the degradation of lamin A mRNA in brain cells. Meanwhile, the 
expression of progerin, the lamin A mutant causing HGPS, was also repressed by this 
mechanism in HGPS mouse model. Their results provide explanations to the normal 
mental development of HGPS patients that is not disrupted by progerin due to the 
3’UTR mediated downregulation (Jung et al., 2012). However, this mechanism is 
brain tissue specific and does not explain the lamin A repression observed in other 
tissues. 
 1.3.3 Protein turnover and stability 
 At the onset of mitosis, both A- and B-type lamins are reversibly 
disassembled in a phosphorylation-dependent manner to facilitate the nuclear 




many mitotic phosphorylation sites, most of which are clustered in the head domain 
and near the nuclear localization signal (NLS) (Simon and Wilson, 2013). 
Specifically, phosphorylation of Ser-22 at head domain, as well as Ser-392, Ser-404 
and Ser-406 at the coiled-coil domain by mitotic cyclin-dependent kinase CDK1 are 
responsible for the depolymerization of lamin A/C filaments during mitosis (Eggert et 
al., 1991; Heald and McKeon, 1990; Peter et al., 1990; Schneider et al., 1999; 
Thompson and Fields, 1996; Ward et al., 1990). The dephosphorylated lamin 
monomers are later re-incorporated into newly forming daughter cell nuclei in 
telophase and G1 stage (Dechat et al., 2008; Fields and Thompson, 1995; Moir et al., 
2000; Thompson et al., 1997).  
Lamin A degradation during apoptosis was accomplished by caspases 
(Lazebnik et al., 1995; Takahashi et al., 1996). This cleavage happens to the aspartic 
acid at position 230 (Asp 230) on lamin A protein (Takahashi et al., 1996). Asp230 
resides in the 2B region of the lamin A central rod domain (Takahashi et al., 1996), 
which is one of the most highly conserved regions across all known intermediate 
filament proteins (Goldman et al., 2002). It has been shown that caspase-uncleavable 
lamin A mutant slowed down the apoptosis progression in HeLa cells, including 
nuclear shrinkage and chromatin condensation (Rao et al., 1996), implying that the 
caspase cleavage of lamin A is critical for the disassembly of the nuclear lamina and 
nuclear breakdown during apoptosis.  
The mechanism controlling lamin proteins’ turnover during interphase has 
always been a mystery. Being proteins providing structural stability, nuclear lamins 




It has been proposed that the mutant progerin might be more stable than wild type 
lamin A, due to the accumulation of progerin during cellular senescence (Goldman et 
al., 2004) and the greater progerin/lamin A ratio at protein level comparing to that at 
mRNA level in HGPS patient fibroblasts (Reunert et al., 2012). However, due to the 
low solubility nature of the lamins, it is a challenge to evaluate their stability using 
traditional methods that largely depend on the solubility of the protein.  
Taken together, although studies mentioned above provide valuable 
information regarding the general parameters for A-type lamins expression, it is 
obvious that more extensive work is required in order to better understand the 
regulation and function of the A-type lamins during development and differentiation. 
 
1.4 Significance of this study 
 As mentioned above, mutations of lamin A are associated with various 
phenotypes in laminopathies in the forms of cardiomyopathy, lipodystrophy, 
muscular dystrophy, tooth disorder, and mandibuloacral dysplasia. However, how 
lamin A mutants cause a wide range of phenotypes affecting multiple tissues and how 
lamin A is regulated are remaining uncertain. Therefore to address these questions, I 
studied the post-translational processing, post-translational degradation and 
transcriptional regulation in my dissertation in order to better understand the function 




 Previously, it has been reported that the anchorage of progerin to the INM 
disrupts normal NE disassembly during mitosis, leading to an accumulation of 
progerin-membrane aggregates in mitosis. Importantly, there is a noticeable delay in 
the recruitment of progerin aggregates back to the nucleus at the end of mitosis.(Cao 
et al., 2007; Dechat et al., 2007) Although progerin is nuclear-localized, the 
cytoplasmic accumulated progerin may also contribute to cell abnormalities. In 
chapter 2, I examined the possible effects of the cytoplasmic progerin by using 
nuclear localization signal (NLS)-deleted progerin and lamin A. Analysis of these 
mutants provides new insights into lamin A processing and a better understanding of 
gene misregulation in muscular dystrophy and cardiomyopathy. 
 It has been suggested that progerin possesses a higher stability than the wild 
type lamin A based on the accumulation of progerin in HGPS patient cell (Columbaro 
et al., 2005; Reunert et al., 2012). To test this hypothesis, I compared the relative 
stability of lamin A, lamin B1 and progerin using a novel comparison system based 
on viral 2A sequence in chapter 3. I not only provide strong evidence showing that 
progerin is more stable than wild type lamin A and lamin B1 in both fibroblasts and 
human bone marrow-derived mesenchymal stem cells, but also proposed an 
alternative method that is able to compare protein stability, especially the protein with 
low solubility, in a more simplified way 
 Chapter 4 focuses on investigating the transcriptional regulation of lamin A in 
lamin A non-expressing cells. In this section, the effect of LMNA first intron was 




cells, LMNA first intron plays an essential role in repressing LMNA expression by 
binding to the transcription factor Sp1 through a highly conserved region. 
 Taken together, my dissertation answers fundamental questions of lamin A 
processing and regulation, and provides new insights into understanding lamin A’s 













Chapter 2: Nuclear localization signal deletion mutants of 
lamin A and progerin reveal insights into lamin A processing 






 Lamin A, encoded by the LMNA gene, is a major component of the nuclear 
lamina in animal cells. As a type V intermediate filament, lamin A forms a dynamic 
network underneath the inner nuclear membrane (INM), providing mechanical 
support to the nuclear envelope (Goldman et al., 2002). Besides the structural 
function, lamin A has been suggested to play essential roles in cell regulation, 
including chromatin organization, transcription and apoptosis (Capell and Collins, 
2006; Csoka et al., 2004; McCord et al., 2013b). These roles are at least partially 
accomplished by direct or indirect interactions with chromosomes and various nuclear 
regulators, including emerin, an integral protein of the INM (Berk et al., 2013; 
Gruenbaum et al., 2002; Holaska and Wilson, 2006; Kubben et al., 2010; Wilson and 
Foisner, 2010).  
 Similar to other intermediate filament proteins, lamin A contains a short 
globular N-terminal head domain, a central α-helical coiled-coil rod domain and a 
long globular C-terminal tail domain. In addition, between the central rod domain and 
C-terminal tail domain, lamin A has a nuclear localization signal sequence (NLS), 
which signals its nuclear residence (Eriksson et al., 2009; Stuurman et al., 1998). 
Moreover, a CaaX motif (C, cysteine; a, aliphatic amino acid; X, any amino acid) is 
located at the C-terminus of lamin A, with an exact sequence of CSIM (cysteine-
serine-isoleucine-methionine) (Holtz et al., 1989).  
 It has been shown that proper processing of the CaaX motif is critical for 




Gelb et al., 2006; Gruenbaum et al., 2005; Shumaker et al., 2005; Yang et al., 2005). 
After the DNA sequence is transcribed and translated into the lamin A precursor 
protein (prelamin A), the cysteine in the CSIM motif is farnesylated by a 
farnesyltransferase (FTase), followed by the removal of SIM by ZMPSTE24 and 
carboxylmethylation by Icmt. In the last step, the final 15 amino acids including the 
farnesylated C-terminus of prelamin A are excised by ZMPSTE24 to allow the 
release of mature lamin A from the INM (Boyartchuk et al., 1997; Dai et al., 1998; 
Goldman et al., 2002; Hennekes and Nigg, 1994; Sinensky et al., 1994; Wright and 
Philips, 2006).  ZMPSTE24 is an integral membrane zinc metalloprotease, which has 
a dual affinity to both the INM and the cytosolic ER membrane (Barrowman et al., 
2008; Barrowman et al., 2012; Bergo et al., 2002), and the INM has been shown to be 
the physiologically relevant compartment for prelamin A processing (Barrowman et 
al., 2008). 
 A wide range of human disorders known as laminopathies are associated with 
mutations of LMNA, among which Hutchinson–Gilford progeria syndrome (HGPS) 
has the most striking premature aging phenotypes (Capell and Collins, 2006; Eriksson 
et al., 2009; Vlcek and Foisner, 2007). HGPS is extremely rare, affecting 1 in 4–8 
million live births. The patients appear normal at birth, but gradually show symptoms 
of accelerated aging after 12 months, and often die of heart attacks or strokes in their 
early teens (Capell and Collins, 2006). The culprit of HGPS is a lamin A mutant 
known as progerin which is caused by a de novo nucleotide substitution from C to T 
at position 1824 of LMNA. The mutation changes no amino acid (G608G), but 




mRNA sequence. The resulting progerin protein thus bears a 50-amino acid in-frame 
deletion that lacks the normal cleavage site of ZMPSTE24 for C-terminal farnesyl 
group release (D’Apice et al., 2004; De Sandre-Giovannoli et al., 2003; Eriksson et 
al., 2003). Therefore, progerin permanently retains the farnesylated C-terminus and 
remains associated with the nuclear membrane, eliciting nuclear blebbings and other 
nuclear abnormalities in HGPS patient cells, including disrupted heterochromatin-
lamin interactions and alterations in gene transcription (Cao et al., 2007; Goldman et 
al., 2004; McCord et al., 2013b). Inhibiting farnesylation of progerin with 
farnesyltransferase inhibitors (FTIs) or mutating CSIM into non-farnesylable SSIM 
relocalizes progerin away from the nuclear envelope (NE) and alleviates the 
prominent nuclear phenotypes (Capell et al., 2005; Toth et al., 2005; Yang et al., 
2005; Yang et al., 2011). 
 Previously, it has reported that the anchorage of progerin to the INM disrupts 
the normal NE disassembly during mitosis, leading to an accumulation of progerin-
membrane aggregates in mitosis. Importantly, there is a noticeable delay in the 
recruitment of progerin aggregates back to the nucleus at the end of mitosis (Cao et 
al., 2007; Dechat et al., 2007). To investigate the possible effects of the cytoplasmic 
progerin aggregates, I created nuclear localization signal (NLS)-deleted progerin and 
lamin A (PGΔNLS and LAΔNLS, respectively). Analysis of these mutants has 






 2.2.1 Deletion of NLS directs lamin A and progerin to the ER 
 In the current study, the NLS was deleted from lamin A (LA) and progerin 
(PG) cDNA sequences, (AAAAAGCGCAAACTGGAG), using a PCR-mediated 
mutagenesis method 48. These newly generated DNA segments were sequenced and 
sub-cloned into a pEGFP-C1 plasmid for expression (Fig 2-1 & 2-2A). To examine 
the proteins’ sizes, I performed Western blot analyses on transiently transfected HeLa 
cells with EGFP-LA, EGFP-PG, EGFP-LAΔNLS or EGFP-PGΔNLS plasmids. As 




Figure 2-1. Sequences and positions of the primers used for generation of the NLS mutants. The 
150bp deletion in progerin cDNA is highlighted in orange. Primers used for NLS deletion by PCR 
mutagenesis are shown in blue. The sequences underlined in blue indicate that the primer sequences 




NLS bearing counterparts, and the endogenous lamin A/C showed a consistent level 




 Next, I examined the cellular localization of EGFP-LAΔNLS and EGFP-
PGΔNLS. I predicted that, without the NLS, neither of them could enter the nucleus. 
Indeed, 24 hours post transfection, I found that the majority of the EGFP-LAΔNLS 
and EGFP-PGΔNLS stayed in the cytosol while EGFP-LA and EGFP-PG co-
localized with lamin B underneath the INM (Fig 2-2C). Interestingly, I found that 
 
 
Figure 2-2. Characterization of the NLS-deleted lamin A and progerin. (A) A schematic diagram of 
the generation of the NLS deletion mutants. Lamin A and progerin NLS deletion (LAΔNLS and 
PGΔNLS) were created via PCR and subcloned into the AscI and XbaI sites of the pEGFP-C1 
plasmid. (B) Western Blot analysis. Protein samples were immunoblotted with antibodies of lamin 
A/C and β-actin. Non-transfected HeLa cells were used as a control (CT). (C) Confocal fluorescence 
images. HeLa cells transiently expressing EGFP-LA, EGFP-PG, EGFP-LAΔNLS or EGFP-PGΔNLS 
(green) were fixed and stained with anti-lamin B1 (red) by immunofluorescence at 24 h post 
transfection. DNA was stained with DAPI (blue). A representative cell under each condition is shown. 




these cytosolic LAΔNLS and PGΔNLS were concentrated at specific locations. 
Moreover, time-course experiments revealed that in the EGFP-LAΔNLS transfected 
cells, diffuse cytoplasmic EGFP signals became detectable after 24 hours post 
transfection, indicating that the EGFP-LAΔNLS accumulates gradually transformed 
into two distinct states with the passage of time: the insoluble state and the soluble 
cytoplasmic state. However, almost all PGΔNLS remained insoluble during the same 
time course (Fig 2-3).    
 
 To elucidate the cytosolic localization of these NLS mutants, I co-stained the 
EGFP-tagged NLS mutants with the anti-KDEL and anti-GM130 antibodies, markers 
for the ER and Golgi apparatus respectively (Munro and Pelham, 1987; Nakamura et 
al., 1995). Microscopic analysis revealed that these mutant aggregates co-localized 
with a sub-domain of the ER while no overlaps were identified between LAΔNLS or  
 
 
Figure 2-3. The time course experiment showing the localization changes of NLS-deleted mutants. 
The signals of EGFP-LA NLS and EGFP-PG NLS were fixed and photographed at 24, 48 and 72 
hours posttransfection. We found that the aggregates of LA NLS gradually solubilized with the 
passage of time. In contrast, the PG NLS aggregates remained associated with the ER throughout the 





Figure 2-4. ER localization of NLS-deleted mutants. (A) Confocal fluorescence images of HeLa cells 
transiently expressing EGFP-LAΔNLS or EGFP-PGΔNLS (green) and stained with anti-KDEL (a 
marker for ER, in red) or anti-GM130 (a marker for Golgi, in red). Scale bar, 10 µm. (B) Confocal 
fluorescence images of HeLa cells cotransfected with either LAΔNLS and PGΔNLS or lamin A and 
progerin. Lamin A and LAΔNLS are in red and progerin and PGΔNLS are in green. The distribution 
of DNA was detected with DAPI in blue. In merged images, yellow indicates overlapping between red 




Figure 2-5. Fluorescence Recovery After Photo bleaching (FRAP) analysis of LAΔNLS and PGΔNLS 
aggregates. (A) Confocal images of the representative pictures at the denoted time points during the 
FRAP experiment. Squares indicate the photobleached areas. The NLS mutants are shown in green. 




PGΔNLS and the Golgi marker GM130 (Fig 2-4A). In addition, I observed a 
complete overlap between the signals of DsRed-LAΔNLS and EGFP-PGΔNLS at 24 
hours post transfection (Fig 2-4B), suggesting that both ΔNLS mutants localized to 
the same ER sub-domain. Consistently, FRAP experiments suggested a comparably 
slow motion of these ER-associated LAΔNLS and PGΔNLS (Fig 2-5). In summary, I 
found that without the NLS, both lamin A and progerin immediately attached to a 
sub-domain of the ER after being synthesized. 
 
 2.2.2 The C-terminal farnesyl group tethers LAΔNLS and PGΔNLS to 
the ER membrane  
 To understand why LAΔNLS and PGΔNLS showed affinities to the ER, I 
hypothesized that both ΔNLS mutants were farnesylated at the C-terminus, which 
tethered these proteins to the ER membrane. To test this hypothesis, I first determined 
the farnesylation status of LAΔNLS and PGΔNLS with a Click chemistry assay on 
transfected HeLa cells (see Methods). As expected(Capell and Collins, 2006; 
Sinensky et al., 1994), wild type mature lamin A was not farnesylated while progerin 
showed positive farnesylation signals due to its inability to be cleaved by ZMPSTE24 
(Fig 2-6A&B). Notably, farnesylation signals were detected in both LAΔNLS and 
PGΔNLS, but the signal of LAΔNLS was significantly weaker compare to that of 
PGΔNLS (Fig 2-6A&B). I reason that the difference in farnesylation levels between 
LAΔNLS and PGΔNLS is likely caused by the cleavage of the C-terminal farnesyl 
group of LAΔNLS by the ER-associated ZMPSTE24, as ZMPSTE24 has been 




(Barrowman et al., 2008).  Supporting this notion, I observed a gradual increase of 
diffuse cytoplasmic LAΔNLS with time, which likely represented the cleaved form of 
LAΔNLS (Fig 2-3).  
 
 To further test this idea, I asked whether blocking the farnesylation of 
LAΔNLS and PGΔNLS could lead to dissociation from the ER membrane. It has 
been shown that farnesylation is abolished when the C-terminal sequence of CSIM on 
lamin A and progerin is mutated into SSIM (Capell et al., 2005; Yang et al., 2006; 
 
 
Figure 2-6. C-terminal farnesyl group tethers LAΔNLS and PGΔNLS to the ER membrane. (A) Click 
chemistry analysis. HeLa cells were transfected with EGFP-LA, EGFP-PG, EGFP-LAΔNLS or 
EGFP-PGΔNLS and labeled with Click-iT farnesyl alcohol, followed by precipitation with GFP-Trap 
beads and detection with 647 Alkyne. Strong farnesylation signals appeared in PG and PGΔNLS 
(PGΔ) lanes, and weak but detectable farnsylation showed in LAΔNLS (LAΔ) lane. (B) 
Quantification of farnesylation levels in (A). The relative farnesylation level was calculated as the 
ratio of the farnesylation signal to the corresponding IP’ed protein signal. (C) Confocal fluorescence 
images of LAssimΔNLS and PGssimΔNLS. Immunofluorescence was performed 24 h after 
transfection. Confocal images show EGFP (green), lamin B1 (red), and DNA (blue). A representative 




Yang et al., 2011). Thus, I generated the SSIM-ΔNLS double mutants of lamin A and 
progerin (LAssimΔNLS and PGssimΔNLS). As expected (Capell et al., 2005; Capell 
et al., 2008; Yang et al., 2008; Yang et al., 2011), the SSIM mutation alone directed 
lamin A and progerin into the nucleoplasm (Fig 2C).  Importantly, when the two 
features ΔNLS and SSIM were combined, the proteins were released from the ER 
into the cytoplasm (Fig 2-6C), validating the idea that the farnesyl groups on the C-
termini of LAΔNLS and PGΔNLS tethered them to the ER membrane.  
 Additional support was obtained with a drug-treatment experiment using 
farnesyltransferase inhibitors (FTIs). When I blocked farnesylation with FTIs, the 
non-farnesylated LAΔNLS and PGΔNLS became soluble in the cytoplasm (Fig 2-7).   
 
 
Figure 2-7. The effect of FTI treatment resembles that of LAssimΔNLS. FTI treatment was performed 
on HeLa cells at 4 h post-transfection for 16 h. The cytoplasm of the ΔNLS mutants transfected cells 
with FTI treatment are outlined by dashed lines. Soluble cytoplasmic EGFP signals are pointed by 
arrows. Confocal images show EGFP (green), lamin B1 (red), and DNA (blue). A representative cell 




 2.2.3 Nuclear targeting of emerin is disrupted by LAΔNLS and PGΔNLS   
 It has been suggested that emerin localization is dependent on A-type lamins 
(Vaughan et al., 2001).  Thus, I investigated whether the distribution of emerin was 
altered by the ΔNLS mutants. In control LA and PG transfected HeLa cells, as 
expected, most of the endogenous emerin co-localized with LA or PG to the nuclear 
rim, outlining the shape of the nucleus (Fig 2-8A, first and third panels). However, in 
the ΔNLS mutant transfected cells, emerin became cytosolic and colocalized with the 
ΔNLS mutants to a sub-domain of the ER (Fig 2-8A, second and fourth panels), 
suggesting that emerin’s nuclear localization is dependent primarily on lamin A. 
Notably, emerin’s normal nuclear localization appeared to be more disrupted by 
PGΔNLS than by LAΔNLS, as the nuclear rim staining of emerin was almost absent 
in PGΔNLS transfected cells as it was still visible in LAΔNLS expressing cells (Fig 
2-8A, second and fourth panels).  
 To determine the potential physical interactions between emerin and the 
ΔNLS mutants, an immunoprecipitation (IP) experiment was carried out using GFP-
Trap beads. Non-transfected HeLa cells were used as a control. I found that emerin 
co-precipitated with EGPF-LA, EGFP-PG, EGFP-LAΔNLS and EGFP-PGΔNLS 
(Fig 2-8B). Consistent with the microscopic observation that PGΔNLS more 
effectively sequestered emerin from the nucleus than LAΔNLS (Fig 2-8A), 
quantification revealed that the interaction of emerin with PGΔNLS was almost twice 






 Taken together, these data showed that the NLS deletion mutants interacted 
and sequestered emerin away from its normal INM localization. Our data suggest that 
emerin is targeted to the nucleus primarily through its interactions with lamin A, and 
there is a stronger affinity between emerin and progerin or PGΔNLS than emerin and 




Figure 2-8. Disrupted emerin localization in cells expressing LAΔNLS or PGΔNLS. (A) Confocal 
fluorescence images. HeLa cells transiently expressing EGFP-LA, EGFP-PG, EGFP-LAΔNLS or 
EGFP-PGΔNLS (green) were fixed and stained with anti-emerin (red) at 24 h post transfection. A 
representative cell under each condition is shown. Scale bar, 10 µm. (B) IP with GFP-Trap®_A beads 
in the transfected HeLa cells. Un-transfected HeLa cells were used as a control (CT). (C) Relative 
intensity of emerin to EGFP-tagged proteins in each immunoprecipitated sample. Band intensities 
were analyzed using ImageJ. Relative intensities were presented as the ratio of emerin to EGFP. Two 




 2.3 Discussion 
 2.3.1 The processing of prelamin A by the INM and ER localized 
ZMPSTE24   
 ZMPSTE24, as one of the key players in the lamin A maturation process, is an 
integral membrane protein (Barrowman et al., 2008; Barrowman et al., 2012; Bergo et 
al., 2002). The cytosolic face of the ER membrane was considered its primary 
residency until recently when Barrowman and colleagues clearly demonstrated that 
ZMPSTE24 was also localized to the INM, and that the nucleus was the 
physiologically relevant compartment where the C-terminal cleavage of prelamin A 
occurred (Barrowman et al., 2008).   
 In this study, I generate the cytoplasmic-resident lamin A mutant LAΔNLS. 
This mutant rapidly tethers to a sub-domain of the ER via its farnesyl tail after being 
synthesized on the ribosomes (Figs 2-4 and 2-6). Notably, I find that over a course of 
72 hours post transfection, the ER-associated LAΔNLS becomes gradually released 
into the cytoplasm (Figs 2-6 & 2-7), which is likely to be resulted from the removal 
of the farnesylated C-terminus. In support of this notion, I detect a reduced level of 
farnesylation in LAΔNLS compared to PGΔNLS, and the double mutant 
LAssimΔNLS and PGssimΔNLS and FTI treatment experiments further support that 
the cytoplasmic soluble fraction of LAΔNLS is not farnesylated (Figs 2-6 & 2-7). 
Based on the previous finding that ZMPSTE24 is a dually localized enzyme 
(Barrowman et al., 2008), I would like to suggest that the cleavage of LAΔNLS’s 




 Interestingly, the Click Chemistry labeling experiment reveals unexpected 
differences in enzymatic activities of the ER-associated and the INM-associated 
ZMPSTE24. As shown in Fig 2-6 A&B, the processing of the wild-type lamin A is 
achieved in an extremely rapid manner on the INM, leading to no detection of the 
farnesylated prelamin A. In contrast, the processing of the ER-associated LAΔNLS 
by the ER-associated ZMPSTE24 appears to be much slower, which resulted in a 
clearly detectable fraction of the farnsylated LAΔNLS at 48 hours post transfection. 
This difference in enzymatic efficiency is intriguing, implying a possibility that some 
unknown nuclear factors might serve as activators to facilitate ZMPSTE24-mediated 
prelamin A processing on the INM.   
 Previously, Barrowman and colleagues have examined the ZMPSTE24 
processing kinetics of a lamin A-tail construct that is fused with a large carrier protein 
HA-pyruvate kinase either with or without the NLS (Barrowman et al., 2008). 
Without the NLS, the lamin A-tail construct produced a cytosolic protein. 
Consistently with my observation, Barrowman and colleagues found that ZMPSTE24 
was functional in both the INM and the ER locations. Interestingly, they found that 
the rate of ZMPSTE24 processing of this lamin A fusion protein was quite similar in 
both locations (Barrowman et al., 2008).   The potential differences in the two studies 
may be caused by many variables including differential access of membrane-bound 
proteins versus cytosolic proteins and differential enzymatic activity of ZMPSTE24 
to LAΔNLS versus Pyruvate kinase-lamin A tail fusion protein. Future studies, with 
controls of these variables, will be required to directly compare the processing 




 2.3.2 Emerin nuclear localization is disrupted by PGΔNLS 
 Mutations and aberrant targeting of emerin cause a number of diseases 
including muscular dystrophy, cardiomyopathy and Emery-Dreifuss muscular 
dystrophy, which is characterized by muscle weakening, contractures of major 
tendons and potentially lethal cardiac defects (Astejada et al., 2007; Holaska and 
Wilson, 2006; Lee et al., 2001; Mislow et al., 2002). Emerin primarily localizes to the 
INM. Previously, Ostlund and colleagues suggested that the N-terminal 
nucleoplasmic domain of emerin was both necessary and sufficient for targeting 
emerin to the INM (Ostlund et al., 1999). However, using SW13 cells that did not 
express lamin A, Vaughan et al. showed that the INM localization of emerin was 
dependent on the lamin A complex containing both lamins A and B (Vaughan et al., 
2001). In support of this argument, it has been shown biochemically that that emerin 
is in complexes with both A and B type lamins (Clements et al., 2000; Vaughan et al., 
2001). 
 In this study, I compartmentalize B type lamins and endogenous lamin A/C to 
the nucleus and LAΔNLS and PGΔNLS to the ER. With this geographic separation, I 
compare the effects of LAΔNLS, PGΔNLS and endogenous lamins on emerin’s 
nuclear targeting. My analyses reveal that at the presence of wildtype lamins A, B and 
C, emerin’s nuclear localization is still mainly dependent on LAΔNLS and PGΔNLS 
(Fig 2-8). Notably, my study suggests that emerin is dominantly extracted from the 
INM by the ER-localized progerin. In support, the IP experiment further suggests that 




LAΔNLS, respectively (Fig 2-8). Future work will focus on determining whether 
other INM proteins are also affected by PGΔNLS.  
 Given the emerging roles of the emerin-lamin A complex in regulating 
muscle- and heart-specific gene expression (Ho et al., 2013), I believe that these new 
insights gained from this study will promote a better understanding of gene 














Chapter 3: Comparing lamin proteins post-translational 
relative stability using a 2A peptide-based system reveals 






 As mentioned earlier, HGPS patients were born with normal appearance, but 
gradually developed accelerated aging symptoms and abnormalities affecting multiple 
tissues due to the accumulation of progerin (Merideth et al., 2008; Pollex and Hegele, 
2004). Previously, higher progerin to lamin A ratio at protein level comparing to that 
at mRNA level has been reported, which was thought due to the decreased amount of 
lamin A in progeria patients (Moulson et al., 2007; Reunert et al., 2012). A fibroblast 
cell line from a 9-year-old HGPS patient with more also showed a greater ratio of 
progerin to lamin A when compared with fibroblasts from younger HGPS patients 
(Columbaro et al., 2005). Furthermore, increased progerin protein levels have been 
observed during cellular senescence of HPGS patience fibroblasts (Goldman et al., 
2004). The increased ratio of progerin to lamin A often accompanies with increased 
severity of the progeria phenotype (Reunert et al., 2012). Therefore, it has been 
assumed that progerin might be more stable than wild type lamin A, possibly due to 
the farnesyl residue still attached to the protein. 
 The commonly used approach of measuring protein stability is pulse-chase 
analysis, which metabolically labels the protein of interest in the cells with a 
radioactive precursor for a short period, then chased with an excess of nonradioactive 
precursor molecules in the culture medium, followed by immunoprecipitation and 
SDS-PAGE to quantify the radiolabeled protein (Fritzsche and Springer, 2014; Zhou, 
2004). However, successful deployment of this method, particularly the step of 
immunoprecipitation, largely depends on the solubility of the target protein.  




(Bertacchini et al., 2013), the tendency of lamin proteins to polymerize into higher 
order insoluble structures in vitro at relatively low critical concentrations (Dechat et 
al., 2010) has a potential to interfere with the accurate assessment of lamin protein 
stability using this methodology. To overcome this limitation, I adapted the novel 
method originally employed by Rodriguez-Contreras and colleagues (Rodriguez-
Contreras et al., 2015) to demonstrate differential glucose transporter stability under 
various growth conditions in the protozoan parasite Leishmania mexicana. This 
simplified approach exploits the unique properties of viral 2A peptide sequences (De 
Felipe et al., 2006) in a manner that does not require immunoprecipitation or 
radiolabelling of cells, and consequently avoids the complications arising from the 
treatment of cells with the translation inhibitor cycloheximide.  
 The 2A peptide was initially discovered and characterized in the foot and 
mouth disease virus (FMDV) which was shown to mediate the production of two 
polypeptides (i.e., 2A and 2B) from the virus’ complex single open reading frame 
(ORF). Translation of the 19 amino acid 2A peptide coding sequence causes an intra-
ribosomal “skipping” event between the final Gly residue of the 2A peptide and the 
first Pro residue of the next polypeptide, causing the release of the first polypeptide 
and reinitiating translation of the second polypeptide starting with Pro (Fig 3-1A) (for 
simplicity, this process will be referred to as “cleavage”) (de Felipe et al., 2010; De 
Felipe et al., 2006; Donnelly et al., 2001; Ryan et al., 1991). Functional 2A peptide-
like sequences have been discovered in several other viruses and retrotransposons, 
and various versions of the sequence have been exploited in molecular biology, gene 




multiple polypeptides from single open reading frames (De Felipe et al., 2006). 




Figure 3-1. Schematic diagrams of processing and creation of 2A constructs. (A) Processing of 2A-
linked constructs. DNA sequences of Polypeptide 1 and 2 are connected by a 2A motif and transcribed 
into a single ORF. The two polypeptides are then separated during translation by a co-translational, 
intraribosomal cleavage right before the proline at the end of the 2A sequence, adding a proline at the 
N-terminus of polypeptide 2. (B) Generation of luciferase-P2A-lamin (lamin A, progerin, lamin B1) 
constructs. Segments of luciferase- P2A and EGFP tagged lamins were amplified and linked together 
via PCR. The subsequent long fragment was subcloned between the BamHI and NotI sites on the 




co-translational cleavage event are inherently transcriptionally and translationally co-
regulated, their relative abundance in the cell is determined solely by their post-
translational stability. Differences in the abundance ratio of the polypeptides among 
cell types or under differential growth conditions will reflect alterations in the post-
translational stability of one or both polypeptides.  It has been reported that the 2A 
sequence from Porcine teschovirus-1 (P2A) has the highest cleavage efficiency 
among all four commonly used 2A sequences (Kim et al., 2011a). Therefore I chose 
to use P2A in our study.  
 I reasoned that fusing Renilla luciferase (Rluc) to various EGFP-tagged lamin 
proteins (lamin A, progerin, and lamin B1) via a P2A peptide sequence (Fig 3-1B) 
would allow the relative post-translational stabilities of the lamin proteins to be 
assessed by comparing the EGFP-lamin:Rluc ratios for each lamin type, since the 
stability of Rluc should be the same in all of the constructs. Different antibodies may 
present a discrepancy in protein detection efficiency, but fusing EGFP to each lamin 
eliminates this variability and allows uniform detection with an anti-EGFP antibody. 
Lamin stability was investigated in lamin A expressing fibroblasts and bone marrow 
mesenchymal stem cells (hBM-MSCs). My results are consistent with the notion that 
progerin is more stable than wild type lamin A. Moreover, FTI treatment significantly 
reduced the post-translational stability of progerin to the level of wild type lamin A, 






 3.2.1 Progerin possesses higher post-translational stability than lamin A 
protein in primary fibroblasts and human bone marrow-derived mesenchymal 
stem cells (hBM-MSCs). 
 To connect Rluc and EGFP-tagged lamin proteins with P2A sequence, I 
applied a series of PCR reactions as illustrated in the schematic Figure 1B. The 
subsequent Rluc-P2A-lamin constructs were then subcloned into the lentiviral 
expression vector for lentiviruses production in HEK293T cells as previously 
described (Xiong et al., 2016). To compare these lamins’ relative stabilities using this 
P2A platform, I first transduced the lentiviruses in primary human fibroblasts and 
human bone marrow-derived mesenchymal stem cells (hBM-MSCs) (Fig 3-2), both 
of which express comparable amounts of endogenous lamin A (Fig 3-3).  In both cell 
types, the majority of the EGFP-lamin proteins were successfully dissociated from 
Rluc protein under the effect of P2A motif, with a small fraction of uncleaved 
products (P2A-LA: 8.8%; P2A-PG:10.7%; P2A-LB1: 25.3%) (Fig 3-3).  The 
expression of each EGFP-lamin was further validated using lamin-specific antibodies 
(Fig 3-2 A&C). The localization of each EGFP-lamin protein was identical to that of 
the corresponding endogenous lamin (Fig 3-2 B&D), suggesting that these EGFP-











 Next, time course experiments were applied to investigate the post-
translational protein stability of the EGFP-lamins within a 7-day period after 
transduction. A gradual accumulation of the three EGFP-tagged lamins was 
noticeably observed in both fibroblasts and hBM-MSCs (Fig 3-4 A&B). Particularly 
 
Figure 3-2. Characterization of 2A constructs in both human fibroblasts and hBM-MSCs (A) Western 
blotting analysis of viral infected human fibroblasts. Protein samples were immunoblotted with 
antibodies of GFP, lamin A/C, lamin B1, luciferase and b-actin. Non-infected fibroblast cells were 
used as a negative control. (B) Confocal fluorescence images. Infected fibroblasts expressing 2A-
lamins (green) were fixed and stained with anti-lamin B1 (red) by immunofluorescence at 48 hours 
post infection. DNA was stained with DAPI (blue). A representative cell under each condition is 
shown. Bars, 10 mm. (C) Western blotting analysis of viral infected hBM-MSCs. Protein samples 
were immunoblotted with antibodies of GFP, lamin A/C, lamin B1, luciferase and b-actin. Non-
infected hBM-MSCs cells were used as a negative control. (D) Confocal fluorescence images of 
infected hBM-MSCs expressing 2A-lamins (green) and stained with anti-lamin B1 (red) by 
immunofluorescence at 48 hours post infection. DNA was stained with DAPI (blue). A representative 
cell under each condition is shown. Bars, 10 mm. P2A-LA, P2A-PG and P2A-LB1 refer to the 





in the fibroblasts, the proteins exhibited a rapid accumulation rate with greater slopes 
at earlier time points (day 2 - 4), and then reached the plateau by day 5 (EGFP-PG 
and EGFP-LB1) or 6 (EGFP-LA) (Fig 3-4E). A similar trend was also observed in 
hBM-MSCs (data not shown).  
 
 To analyze the post-translational stability of these EGFP-tagged lamin 
variants, the EGFP signal was normalized to Rluc for quantification and the analysis 
presents an average of the plateau period from day 5 to day 7. The Rluc and the 
EGFP-tagged lamin/progerin are encoded within the same mRNA, and their 
translation initiates from the same ATG. Because the P2A-mediated “cleavage” that 
separates these two proteins occurs during translation, the post-translational stability 
 
 
Figure 3-3. Full gel image of fibroblasts expressing Rluc-P2A-EGFP-lamin A (P-LA), Rluc-P2A-




of the Rluc and EGFP-lamin proteins is completely independent.  Normalization to 
the co-translated Rluc control renders the contribution of all transcriptional and post- 
 
transcriptional regulatory mechanisms, except post-translational protein stability. 
Thus, we reason that the steady state levels of EGFP-lamins (from day 5 to day 7) 
 
 
Figure 3-4. Comparing relative stability of lamin A, progerin and lamin B1 in fibroblasts and hBM-
MSCs. (A) Western blotting analysis on time course of viral infected human fibroblasts. Protein 
samples were immunoblotted with antibodies of GFP, luciferase and b-actin. (B) Time course of viral 
infected hBM-MSCs were analyzed by Western blotting. Antibodies of GFP, luciferase and b-actin 
were utilized for immunoblotting. (C) and (D) are quantifications of lamins’ relative stabilities in (A) 
and (B), respectively. The relative stability was calculated as the intensity ratio of EGFP/luciferase. 
Bar graph shows the average of day 5 to day 7 data. Results were generated from 3 biological 
replicates. *P < 0.05, **P < 0.01. (E) Representative plot of EGFP/Rluc ratio during time course 
experiment for fibroblasts. P2A-LA, P2A-PG and P2A-LB1 refer to the constructs of luciferase-P2A-




should directly reflect the post-translational stability of these proteins when 
normalized to Rluc. I further suggest that differences in the EGFP/Rluc ratio between 
the various EGFP-lamin/progerin fusions should reflect differences in relative post-
translational stability. Based on this method, I found that among the three lamins, 
EGFP-progerin possessed the greatest relative stability in both cell types, followed by 
EGFP-lamin A and EGFP-LB1 (Fig 3-4 C&D). Interestingly, EGFP-lamin B1 was 
the least stable lamin variant in fibroblasts (Fig 3-4 C) and exhibited a stability 
similar to EGFP-LA in hBM-MSCs (Fig 3-4 D), despite the fact that it, like progerin, 
remains farnesylated. 
 3.2.2 Endogenous lamin A may not alter the post-translational stability of 
exogenously expressed A type lamin proteins 
 Because the 2A peptide-mediated reporter system relies on overexpression of 
exogenous EGFP-lamin proteins, which are expected to interact with endogenously 
encoded lamins, I wanted to determine if the presence of endogenous lamin A/C 
influenced the stability of the EGFP-lamin proteins. To address this issue, I used wild 
type mouse embryonic fibroblasts (MEF) and lamin A null MEF lines for lentiviral 
transduction.  Like in fibroblasts and hBM-MSCs (Figs 3-2 & 3-4), the fused proteins 
were successfully expressed and “cleaved” in both types of MEFs (Fig 3-5A).  
 Next, the post-translational stability of EGFP-LA and EGFP-PG was 
determined by time course experiments from 4 days to 6 days post-transduction when 
the steady state expression was achieved (Fig 3-5B). The quantification analysis was 







Figure 3-5. Examining lamin relative stabilities in both LAC/C and LA-/- MEFs. (A) Western blotting 
analysis of viral infected MEF cells. Proteins were probed with antibodies of GFP, human lamin A/C 
(mAB3211, which only recognizes human lamin A/C), lamin A/C (N-18), luciferase and b-actin. Non-
infected cells were used as a negative control. (B) Time course of viral infected hBM-MSCs were 
analyzed by Western blotting. Antibodies of GFP, luciferase, human lamin A/C and b-actin were 
utilized for immunoblotting. (C) The quantification was calculated as the intensity ratio of 
EGFP/luciferase. Bar graph shows the average of day 4 to day 6 data. Results were generated from 3 
biological replicates. P2A-LA, P2A-PG and P2A-LB1 refer to the constructs of luciferase-P2A-lamin 




3-4. I found that the relative protein levels of EGFP-LA and EGFP-PG in wild type 
and LA null MEFs were essentially identical, suggesting the post-translational 
degradation of exogenously expressed human A type lamins was not impacted by the 
presence of endogenous mouse lamin A.  
 It should be noted that these wild type or lamin A null MEF cells were derived 
from mouse embryos. This species-mismatched cell line might explain why I did not 
observe a significant increase in the relative amount of human progerin compared to 
human lamin A.  While the results from this experiment implies that the presence of 
endogenous lamin A/C does not affect the post-translational stability of the 
exogenously expressed EGFP-lamins, MEFs lines are not the optimal system and 
further validation using a human LA/C null fibroblast or MSC lines are desired.   
 3.2.3 FTI treatment reduces progerin stability in fibroblasts 
 Farnesyltransferase inhibitors (FTI) block farnesylation of progerin, relocalize 
the protein away from the nuclear envelope, and alleviate the prominent nuclear 
phenotypes in human progeria fibroblasts (Capell et al., 2005; Gordon et al., 2012a; 
Toth et al., 2005; Yang et al., 2006). The past studies on FTI did not elaborate how 
inhibition of farnesylation by FTI affects post-translational lamin protein stability, 
specifically in the lamins with farnesyl tail such as progerin and lamin B1. To study 
this, the P2A-EGFP-lamin system was applied in fibroblast cells treated with FTI for 
six days (Fig 3-6A). During the treatment, nucleoplasmic aggregates of EGFP-lamin 
A, EGFP-progerin or EGFP-lamin B1 were observed (Fig 3-7).  The quantification 






Figure 3-6. Effects of FTI on lamins relative stabilities in human fibroblasts. (A) Western blotting 
analysis of viral infected fibroblasts upon the treatment of FTI. DMSO treated cells were mock 
control. (B) Quantification of the relative stability in (A) is presented as EGFP/luciferase ratios. Bar 
graph shows the average of day 4 to day 6 data. Results were generated from 3 biological replicates. * 
P < 0.05, ** P < 0.01. P2A-LA, P2A-PG and P2A-LB1 refer to the constructs of luciferase-P2A-lamin 




Figure 3-7. Representative confocal images of FTI treated fibroblasts for 4 days. Green indicates 
EGFP signals. P2A-LA, P2A-PG and P2A-LB1 refer to the constructs of luciferase-P2A-lamin A, 





protein steady state was achieved (Fig 3-6B). Interestingly, I found that FTI 
significantly reduced progerin’s stability to the level of wild type lamin A, whereas 
lamin A had no significant changes in stability after FTI treatment (Fig 3-6B). 
 To my surprise, the other farnesylated lamin, EGFP-LB1, displayed an 
opposite response to FTI treatment, where its post-translational stability was largely 
increased by farnesylation inhibition. Yet, Adam and his colleagues have previously 
reported reduced endogenous lamin B1 expression in fibroblasts treated with FTI 
(Adam et al., 2013a).  To address this potential discrepancy, I compared endogenous  
 
 
Figure 3-8. Effects of FTI on relative protein abundance of endogenous lamin B1 and exogenously 
expressed EGFP-lamin B1 in human fibroblasts. (A). Western blotting analysis of viral infected and 
un-infected fibroblasts upon the treatment of FTI. DMSO treated cells were mock control. (B) 
Quantification of the relative protein abundance of endogenous lamin B1. (C) Quantification of the 
relative protein abundance of exogenously expressed EGFP-lamin B1. Bar graph shows the average of 
day 4 to day 6 data. Results were generated from three biological replicates. * p<0.05. P2A-LA, P2A-






LB1 and exogenous LB1 protein levels in FTI treated and untreated fibroblast cells 
(Fig 3-8). In agreement with Adam et al., the endogenous LB1 protein decreased with 
FTI treatment in both non-infected and P2A-LB1 lentiviral-infected fibroblasts (Fig 
3-8 A&B).  Consistently, I observed an increased level of exogenously expressed 
EGFP-LB upon FTI treatment (Fig 3-8C). As suggested by Adam et al., the decreased 
endogenous lamin B1 level was likely due to the down-regulated lamin B1 mRNA by 
FTI treatment. Whereas for EGFP-lamin B1, its transcription is driven by a spleen 
focus-forming virus (SFFV) promoter, which may be independent of the influence of 
FTI. Therefore, the accumulation of EGFP-lamin B1 in the FTI treatment, as revealed 




 In this study, I employed a viral P2A-sequence based comparison system to 
demonstrate that progerin is post-translationally more stable than wild type lamin A 
in fibroblasts and hBM-MSCs. My results are in agreement with the previous 
observation that progerin protein accumulates during cellular aging (Cao et al., 
2011a; Eriksson et al., 2003; Goldman et al., 2004). FTI significantly reduced 
progerin’s post-translational stability to the level of wild type lamin A, which 
provides additional evidence to support the beneficial effects of FTI in HGPS cells, 
animal models and patient clinical trials (Capell et al., 2008; Gordon et al., 2012a; 




translational stability was increased upon the treatment of FTI. A previous study 
reported a reduction in endogenous lamin B1 protein in FTI-treated cells, which was 
likely due to the down-regulation of lamin B1 mRNA level by FTI (Adam et al., 
2013b). In my experiment, the transcription of the exogenous EGFP-lamin B1 was 
driven by an SFFV promoter which does not show a noticeable response to FTI 
treatment (Fig 3-8).  Furthermore, in the P2A system, the normalization of EGFP-
lamins to the Rluc control accounts for any differences in mRNA abundance or 
translation rate. Thus, only the post-translational stability of EGFP-lamin B1 was 
assessed and compared across samples. My study suggests that normally farnesylated 
LB1 is less stable than the non-farnesylated LB1. Previous findings have shown that 
disrupted farnesylation by mutations in the CAAX motif of LB1 mislocalize the 
protein to the nucleoplasm (Maske et al., 2003; Verstraeten et al., 2011). A recent 
study has reported that lamin B1 degradation involves nucleus-to-cytoplasm vesicular 
transport that delivers lamin B1-LC3 to the lysosomes (Dou et al., 2015). Based on 
these data, a possible explanation is that the removal of the farnesyl tail from lamin 
B1 may disassociate the protein away from the nuclear lamina, which disrupts the 
LC3-mediated exporting vesicle formation, causing an increase in the stability of 
lamin B1.  
 I show that the P2A sequence efficiently mediated the disassociation of Rluc 
and EGFP-tagged lamin proteins in different cell lines, including fibroblasts, hBM-
MSCs and MEFs, suggesting the extensive applicability of this method. The 
normalization of steady-state levels of EGFP-tagged lamins to those of the 




mRNA stability, and translation rates between samples, and allowed differences in 
post-translational stability between the various lamins to be inferred. The main 
advantages of the P2A peptide-mediated post-translational reporter system are that it 
is much simple to implement, it avoids potentially confounding pleiotropic effects 
from cycloheximide inhibition of translation, and it provides a means to look at the 
relative stability of insoluble proteins. One of the main drawbacks of the technique in 
its current configuration is that it cannot provide a direct measurement of protein half-
life, and only allows relative changes in protein stability to be inferred for a protein 
under different growth conditions (Rodriguez-Contreras et al., 2015), or between 
protein variants as presented here for the lamins. Rodriguez-Contreras and colleagues 
used a variation of the P2A-peptide technique to examine changes in stability of the 
LmxGT1 glucose transporter in response to glucose starvation, and demonstrated that 
the fold-change in LmxGT1 stability determined via this technique was essentially 
identical to the fold-change in half-life determined via the cycloheximide block 
technique (Rodriguez-Contreras et al., 2015). This serves as a validation of the 
underlying concepts of the technique, and emphasizes the direct relationship between 
protein half-life and steady state protein abundance. I have noticed that the dynamics 
of normalized protein accumulation (lamin/luc) over time were highly reproducible 
and specific for each lamin type (Fig 3-4E). Since the rate of increase in protein 
abundance should be directly proportional to the half-life of the protein, it may be 
possible to use this rate to calculate protein half-life in a manner similar to the 
“approach to steady-state labeling” method described previously (GREENBERG, 




and the rate of specific mRNA that accumulated at a steady-state level was measured. 
Then the half-life of the mRNA was calculated based on the time required to reach its 












Chapter 4: LMNA first intron mediates transcription 






 The expression of lamin A is suppressed in undifferentiated cells like 
embryonic stem cells, and some highly proliferative cells, such as leukemias and 
lymphomas, and is induced upon cell differentiation (Broers et al., 1997; Stadelmann 
et al., 1990). This tissue- and stage-specific expression pattern implies that lamin A 
expression is highly regulated.  
 It was first thought that the regulation of lamin A expression is primarily 
occurred at the transcriptional level (Hamid et al., 1996; Lin and Worman, 1997; 
Mattia et al., 1992). Several transcriptional regulation motifs and transcription factor 
binding sites have been found on the LMNA promoter region. For example, a retinoic 
acid-responsive element (L-RARE) was identified within the LMNA promoter, which 
is bound by several transcription factors including c-Jun and Sp1/Sp3 (Okumura et al., 
2004) and responsible for retinoic acid-mediated activation of lamin A/C in mouse 
embryonic carcinoma cells (Lebel et al., 1987). There are also other regulatory motifs 
in the LMNA promoter that may interact with the transcription factors Sp1/3, c-Jun, 
and c-Fos, and the transcriptional coactivator CREB-binding protein (Janaki Ramaiah 
and Parnaik, 2006; Muralikrishna and Parnaik, 2001). The CpG island 
hypermethylation of LMNA promoter has also been examined. However, it does not 
explain lamin A/C inactivation for all the tested hematologic malignancies (Agrelo et 
al., 2005).  
Meanwhile, studies of lamin A/C post-transcriptional regulation have also 




embryonal carcinoma cells is considered to be a post-transcriptional event, due to the 
unchanged LMNA transcription rate during retinoic acid-induced differentiation 
(Lanoix et al., 1992). Furthermore, Jung and his colleagues illustrated that a brain-
specific microRNA, miR-9, mediates the suppression of lamin A expression by 
targeting to the 3’UTR of lamin A transcripts in brain cells (Jung et al., 2012). 
Apparently, there are still many uncertainties about the regulation of lamin A/C 
during differentiation and development. More extensive studies are required in order 
to further unravel the puzzle. 
 Therefore, other regions outside of the promoter were explored. The LMNA 
first intron, which is ~16kb in length, contains the transcription initiation site of the 
male germ-cell-specific lamin C2 isoform (Nakajima and Abe, 1995). DNase 
hypersensitive site clusters were shown to be present within the first intron and 
associated with lamin A/C expression (Nakamachi and Nakajima, 2000b). Binding 
sites for transcription factors hepatocyte nuclear factor-3β and retinoic X receptor β 
(RXRβ) have also been reported (Nakajima and Abe, 1995). 
 In this chapter, I investigate the regulation of lamin A expression in human 
promyelocytic leukemia HL60 cells by elucidating the role of LMNA first intron in 
transcription control of LMNA gene expression through a combination of 
bioinformatic and molecular biology approaches. I found out that a highly conserved 
region in the LMNA first intron is closely associated with lamin A/C repression in 




Please note that I refer fibroblasts as lamin A/C positive cells and HL60 as lamin A/C 
negative cells based on the lamin A/C expression status throughout this chapter. 
 
4.2 Results 
 4.2.1 Conserved regions with potential transcriptional regulatory 
activities are identified in the LMNA first intron  
 Using UCSC genome browser, we found that the first intron of LMNA gene is 
very special. Not mention its unusual size of 16kb, which takes up 60% of the whole 
LMNA gene length, the first intron bears many features that are not usually seen in 
introns. For example, bindings of transcription factors and histone modifications have 
been reported in LMNA first intron, including the markers that are commonly 
associated with active transcription of nearby genes, such as H3K4me3 and H3K27ac 
(Fig 4-1). In addition, by comparing the conserved sequences among 44 mammalian 
species using the data from UCSC genome browser, the first intron of LMNA was 
shown to contain many conserved regions (shown as peaks in the figure) whose 
conservatory is compatible with that in exons (Fig 4-1). On the contrary, other LMNA 
introns (eg. the second intron) do not show these features. 
To investigate the role of LMNA first intron in lamin A expression regulation, 
I first identified a total of five highly conserved regions (Con 1-5) across the entire 
LMNA first intron using bioinformatic approaches (Fig 4-2A). Next, luciferase 
activity assays of Con 1, 3, 4, and 5 were performed on transiently transfected HeLa 





These luciferase constructs were created by inserting each of the conserved regions 
independently to the upstream of the basal promoter in a luciferase reporter plasmid. 
Conserved region 2 (Con 2) was not tested due to certain cloning difficulties. The 
results showed that the conserved region 1 (Con1), which is around 1.2kb 
downstream of LMNA transcription start site (TSS), exhibited the highest luciferase 
 
 
Figure 4-1: Screen shot of LMNA gene structure information from UCSC genome browser. From the 
bottom to the top: LMNA gene Refseq and common isoforms; Conservatory generated from 44 
mammalian species; A few histone modification marks across the gene; Conserved transcription factor 




activity of 7-fold upregulation comparing to the control group. On the contrary, 
conserved region 5 (Con 5), which is about 270bp to the 3’ of LMNA first intron, 
significantly reduced the luciferase activity to a barely detectable level. The other two 
tested regions, Con 3 and 4, had no notable effects on the transcription of luciferase 
constructs (Fig 4-2B). These data suggested that both Con 1 and Con 5 might contain  
 
motifs that possess certain transcription regulatory activity. My attention was 
immediately drawn to Con 5, because it showed a transcription repression activity, 
which may contribute to the repressed lamin A expression in certain cell types. 
Therefore my following study is mainly focused on Con 5. 
 
 
Figure 4-2. Functional analysis of LMNA first intron. (A) Five highly conserved regions identified 
within the first intron of LMNA. (B) Relative luciferase activities of the five conserved regions in 




 4.2.2 Sp1, together with its co-factors E2F1 and HDAC2, are predicted to 
be the potential regulatory element binding to Con 5 in the lamin A first intron 
 To further investigate the role of Con 5 in lamin A transcription regulation, I 
functionally analyzed Con 5 in two types of cell lines, fibroblasts which express a 
high levels of lamin A, and the leukemia cell line HL60 which has very low lamin A 
expression (Fig 4-3B). By analyzing the ENCODE DNase-seq data of fibroblasts and 
HL60 cells, I found that the chromatin around Con 5 region is open for protein 
binding in both of the cell lines. Next, a Position Weight Matrix (PWM) scan was 
used to predict transcription factors (TFs) that may bind to Con 5 region. False 
positive binding candidates were removed by analyzing of DNase-DGF data of the 
Con 5 region across several cell lines. Last, the candidate list was further narrowed 
down by comparison against the ENCODE ChIP-seq data around Con 5 region. Only 
two true-positive candidates were left, Sp1 and REST. REST (RE1-Silencing 
Transcription factor) was subsequentially excluded after considering that it functions 
in the repression of neural genes in non-neuronal cells (Chong et al., 1995; Coulson, 
2005), whereas LMNA does not belong to that category. Transcription factor Sp1 
(specificity protein 1) is a ubiquitously-expressed transcription factor involved in 
many cellular processes, including differentiation, proliferation, cell cycle regulation, 
apoptosis and tumorigenesis (BLACK et al., 2001; Tan and Khachigian, 2009). It 
often interacts with two other cofactors, such as E2F1 and HDAC2, to regulate gene 
expression (Doetzlhofer et al., 1999; Lin et al., 1996; Won et al., 2002). Therefore I 




Next, the expression levels of Sp1, E2F1 and HDAC2 were examined at 
mRNA and protein levels in both fibroblasts and HL60 cells. A real-time quantitative 
reverse transcription PCR was first employed to measure the mRNA expression level 
of lamin A and the three candidates. As expected, lamin A was highly expressed in 
the fibroblasts, but largely repressed in HL60 cells (Fig 4-3A). To my surprise, the 
mRNA levels of Sp1, E2F1 and HDAC2 were low in fibroblasts but significantly 
higher in HL60 cell (Fig 4-3A). In support, Western Blotting analysis demonstrated 
highly consistent results (Fig 4-3B&C). Fibroblasts displayed an intensive amount of 
lamin A/C proteins but little amount of the Sp1, E2F1 and HDAC2. On the contrary, 
these candidates showed strong bands in HL60 cells, whose lamin A/C proteins were 
barely detectable (Fig 4-3B&C). Those data suggested that the three candidates were  
 
 
Figure 4-3. Reciprocal expression pattern between endogenous lamin A and the protein candidates 
Sp1, E2F1 and HDAC2 . (A) mRNA expression levels of LMNA, SP1, E2F1 and HDAC2 in 
fibroblasts and HL60 cells. * p<0.05, **** p<0.0001. (B) Western Blot analysis of fibroblasts and 
HL60. Protein samples were immunoblotted with antibodies of Sp1, E2F1, HDAC2, lamin A/C and β-




differentially expressed between fibroblasts and HL60s. Based on the reciprocal 
expression pattern between lamin A and the three candidates in fibroblasts and HL60s, 
I hypothesize that Sp1 may play a role in repressing lamin A expression by binding to 
the Con5 region in the LMNA first intron in HL60 cells. It may form a repressive 
complex with E2F1 and/or HDAC2 at Con5. 
 4.2.3 Sp1, E2F1 and HDAC2 expression levels are inversely associated 
with the lamin A amounts in HL60 and fibroblasts 
 To further explore the functional association of the three protein candidates 
with lamin A expression, I decided to manipulate the levels of Sp1, E2F1 or HDAC2 
protein and examine their effects on lamin A expression. First, Sp1, E2F1 and 
HDAC2 were knocked down by 40-50% individually using siRNAs in HL60 cells 
(Fig 4-4A). As a consequence, increased lamin A/C mRNA levels were detected upon 
the inhibition of these candidates, among which Sp1 exhibited the most significant 
effect (Fig 4-4A). The unregulated lamin A/C expression was confirmed]\ at the 
protein level by Western Blotting analysis (Fig 4-4B). Although the expression of 
LMNA gene is nearly absent in HL60 cells, detection of traces of lamin A/C proteins 
has been reported in previous studies (Kaufmann, 1992; Lin and Worman, 1997; 
Olins et al., 2001). With relative long exposure time I was also able to observe low 
but detectable level of lamin A/C in scramble siRNA treated group (Fig 4-4B&C). 
Consistent with qPCR data, increased lamin A/C protein amount was detected in 
target protein siRNA treated samples (Fig 4-4B&C).  
 In addition to HL60 cells, the effects of the three candidates on lamin A 





Unlike HL60 cells, fibroblasts have relatively low level of Sp1, E2F1 or HDAC2 
(Fig4-3). To further determine the reciprocal correlation between lamin A and the 
candidate proteins, I independently overexpressed GFP tagged Sp1, E2F1 and 
HDAC2 in fibroblasts (Fig 4-5). As a result, a 20-30% decrease of LMNA mRNA was 
detected in the candidate protein overexpression groups (Fig 4-5A). Moreover, lamin 
A/C protein levels were reduced to approximately half of the control group (Fig 4-
5B&C). Together, our data suggested an inverse relationship between Sp1, E2F1 and 
HDAC2 and lamin A expression, which may contribute to the repressed lamin A 
transcription in HL60 cells. 
 
Figure 4-4. siRNA knocking down of Sp1, E2F1, HDAC2 induces lamin A transcription in HL60. (A) 
mRNA expression levels of LMNA, Sp1, E2F1 and HDAC2 in HL60 cells. * p<0.05. (B) Western 
Blot analysis. Protein samples were immunoblotted with antibodies of lamin A/C and β-actin. (C) 





 4.2.4 Repressive effects of SP1 on lamin A expression depends on its 
binding to Con5 in LMNA first intron 
  My data suggestes that Sp1, E2F1 and HDAC2 are closely associated with 
lamin A expression repression. My next goal is to understand the underlying 
mechanism of this regulation. I started with Sp1, which is one of the most well 
characterized transcriptional factors (Vizcaíno et al., 2015). It was first recognized as 
a constitutive transcription activator of housekeeping genes and other TATA-less 
 
 
Figure 4-5. Overexpression of SP1, E2F1, HDAC2 decrease lamin A transcription in fibroblasts. (A) 
mRNA expression levels of LMNA, SP1, E2F1 and HDAC2 in fibroblasts cells. * p<0.05, ** p<0.01, 
*** p<0.001, **** p<0.0001. (B) Western Blot analysis. Protein samples were immunoblotted with 
antibodies of Sp1, E2F1, HDAC2, lamin A/C and β-actin. (C) Quantification of lamin A/C protein 




genes (Azizkhan et al., 1993; Pugh and Tjian, 1990; Suske, 1999), and later on found 
to be involved in many other processes, including cell growth control and 
tumorigenesis (Li and Davie, 2010). To elucidate whether the transcription regulatory 
activity of Sp1 depends on the Con 5 region, I knocked down Sp1 using siRNA in 
HeLa cells (Fig 4-6A) and re-examined the luciferase activity of Con 5 (Fig 4-6B). 
Surprisingly, the luciferase activity of Con 5 was significantly increased upon the Sp1 
siRNA silencing when comparing to the cells transfected with scrambled siRNA (Fig 
4-6B, Con5). Conversely, HeLa cells transfected with the control luciferase vectors 
(CT) did not show distinct alternation on the luciferase activities between scrambled 
and Sp1 siRNA treated groups (Fig 4-6B, CT). These results imply that the 
transcription repression of Sp1 is largely Con 5-dependent, likely through a direct 
binding between Sp1 and Con 5 DNA sequence. However, this speculation needs 
further investigation. To determine the interaction between Sp1 and Con 5 sequence 
in HL60s and GFP-Sp1 overexpressed fibroblasts, chromatin immunoprecipitation 
(ChIP) will be performed.  
 
Figure 4-6. Identification of SP1/Con5 association. (A) Western Blot analysis on siRNA transfected 
HeLa. Protein samples were immunoblotted with antibodies of Sp1 and β-actin. (B) Relative 
luciferase activities of Con5 in Sp1 siRNA transfected HeLa cells. Quantification was done by student 





Lamin A and C are the two major isoforms generated from LMNA gene. 
Although being found in many somatic cell cultures and a variety of tissues, 
expression of lamin A is highly repressed in undifferentiated cells and cells with high 
proliferative rates (Broers et al., 1997; Stadelmann et al., 1990). The regulation of 
lamin A during differentiation and development has been a long-lasting question that 
required more studies to elucidate.  Besides the proximal promoter region, regulatory 
motifs have been suggested to reside in regions of 5’ distal region, 3’ UTRs and the 
large first intron of LMNA (Lin and Worman, 1993; Nakamachi and Nakajima, 
2000a). In addition to its unusual size, the first intron of LMNA surprisingly exhibits 
many features similar to exons, including high conservatory, active histone 
modifications, transcription factor bindings, etc., suggesting a potential functionality. 
Therefore in this study, I zoomed into the very special first intron of LMNA, and 
explored its role in the suppression of lamin A expression. Based on the comparison 
among 44 mammalian species, a total of five highly conserved regions were 
identified in the first intron. Con 5 region showed a high level of transcription 
repression activity in luciferase activity assay. Moreover, it is predicted to be 
differentially bound by Sp1, E2F1 and HDAC2 in lamin A nonexpressing cells but 
not in lamin A positive cells. These findings led us to further investigate the 
connection between lamin A expression and the three candidates. Surprisingly, lamin 
A expression was inversely affected by the three proteins in lamin A-expressing 
fibroblasts and lamin A-nonexpressing HL60 cells. In particular Sp1 has a repression 




interaction with the Con5 region. Together, my study reveals the repressive role of 
LMNA first intron in lamin A expression and provide strong evidence for introns 
being involved in gene regulation. 
The relevance of introns in gene regulation of intermediate filaments has been 
reported. An example of such an analysis is keratin 18 (K18), which is expressed in 
diverse simple epithelial tissues and in various carcinomas (Blumenberg). It was 
shown that both enhancer and silencer elements embedded in the first intron of the 
K18 gene are responsible for the regulation of the gene expression during cell 
differentiation induced by retinoic acid (Pankov et al., 1994). The Con5 region 
identified in my study can be considered as an inhibitory element that contributes to 
the cell-type-specific expression of lamin A. However, it still needs be determined 
whether the first intron is involved in lamin A regulation during differentiation and 
development. 



















 My doctoral research presented in this dissertation studies lamin A processing 
and regulation in from the following three aspects:  
 First, based on a noticeable delay observed in the recruitment of progerin back 
to the nucleus at the end of mitosis, I examined the potential effects of cytoplasmic 
lamin A and progerin using molecular and biochemistry approaches in chapter 2. To 
start, I generate the cytoplasmic-resident lamin A and progerin mutants LAΔNLS and 
PGΔNLS by deleting the NLS from both lamin A and progerin. I found that both 
mutants are farnesylated and rapidly tethers to a sub-domain of the ER through the 
farnesyl tail after being synthesized. Additionally, I noticed that the ER-associated 
LAΔNLS becomes gradually released into the cytoplasm, which is likely due to the 
removal of the farnesylated C-terminus by ER-associated ZMPSTE24. Whereas 
PGΔNLS, which cannot be processed by ZMPSTE24, remains ER-associated. A 
much higher level of farnesylation was observed for LAΔNLS comparing to wild 
type lamin A, suggesting a differences in enzymatic activities between the ER-
associated and the INM-associated ZMPSTE24. Moreover, the nuclear localization of 
an INM protein emerin is largely disrupted by LAΔNLS and, especially, PGΔNLS. 
Since mutations of emerin have been connected with cardiomyopathy and muscular 
dystrophy, my data indicates that the cytoplasmic progerin may also lead to these 
pathologic phenotypes observed in HGPS patients. 
 Second, I compared the relative protein stabilities among lamin A, progerin 




more stable than wild type lamin A, and what effects does farnesyl tail have on 
protein stability. To overcome the limitation of traditional methods on stability testing 
of proteins with low solubility like nuclear lamins, I first established a comparison 
platform based on a viral 2A sequence, which mediates the co-translational cleavage 
of multiple polypeptides from a single ORF. In this system, I used Renilla luciferase 
as a normalization factor and linked it with different EGFP-tagged lamin proteins 
through the 2A motif. By normalizing EGFP to luciferase, I have control of the 
transcription rate, mRNA stability and translation rate between different lamin 
constructs. Thus, the relative stability of the lamins can be easily compared by 
Western Blotting analysis. Taking the advantage of this system, I compared the 
relative stability of lamin A, progerin and lamin B1 in different cell types, including 
human fibroblasts and bone marrow-MSCs. My data clearly shows that progerin 
possesses a significantly higher post-translational relative stability than both lamin A 
and lamin B1 in both tested cell lines. In addition, the relative stability of exogenous 
expressed proteins is not altered by the endogenous lamins, indicating the feasibility 
of my comparison system. Inhibition of farnesylation by FTI treatment largely 
reduced the relative stability of progerin. This can be added to the explanation of the 
clinical rescuing effects on HGPS patients. More interestingly, the relative stability of 
lamin B1, which naturally carries a farnesylated C-terminus, was not decreased upon 
FTI treatment. Instead, it was slightly increased. Therefore, my data implies that 
elimination of farnesyl tail does not always equal to elevated protein stability. For 





 From there I went back to the very fundamental level and explored the 
transcription regulation of lamin A gene in chapter 4. Unlike other introns in LMNA 
gene, LMNA first intron exhibits many features that normally are observed in exons, 
such as TF bindings, active histone modifications and conservatory. To investigate 
whether it is involved in lamin A regulation, I first functionally analyzed the first 
intron using a bioinformatics approach. A total of five highly conserved regions were 
identified across 46 mammalian species, among which the first conserved region 
(Con1) presented the highest transcriptional regulation activity. Next, I narrowed 
down three DNA binding proteins that specifically bind to Con5 region and highly 
expressed in lamin A non-expressing cell lines but not in lamin A expressing cells. 
These proteins, Sp1, E2F1 and HDAC2, showed a reciprocal expression pattern with 
lamin A between human fibroblasts (lamin A positive) and HL60 cells (lamin A 
negative). Therefore, I hypothesized that Sp1, E2F1 and/or HDAC2 might negatively 
regulate lamin A expression by binding to the Con5 region on LMNA gene. To study 
the connection between Sp1, E2F1, and HDAC2 and lamin A expression, I further 
manipulated the level of these three proteins and observed the corresponding changes 
of lamin A expression: overexpression of Sp1, E2F1, or HDAC2 led to a decreased 
lamin A expression in fibroblasts, whereas silencing of these three proteins resulted in 
a increase of lamin A expression in HL60 cells. Moreover, by combination of Sp1 
siRNA treatment and luciferase activity assay, I provided the evidence that the 
transcriptional regulatory activity of Sp1 is Con5 dependent. This dependence might 
be accomplished by the interaction between Sp1 and Con5, which plays a role on 




5.2 Future directions 
 Mutations in LMNA are mainly responsible for two groups of diseases, 
affecting highly specialized tissues: dystrophies of skeletal and/or cardiac muscles, 
and partial lipodystrophies (Vigouroux and Bonne, 2013). Especially for HGPS 
mutation, these defects exhibit in combination and with the most severities. However, 
the pathophysiology of the diseases linked to LMNA mutations remains unclear. 
Considering the widespread expression of lamin A/C in differentiated cells, it is 
puzzling that these diseases are exhibited in a tissue-specific manner. One possibility 
is the alternated protein-protein interactions between lamin A and the mutations of the 
binding partners of lamin A. One example is the emerin protein, whose mutants have 
been shown to be associated with X-linked Emery-Dreifuss muscular dystrophy (XL-
EDMD) (Bione et al., 1994). This disease is overall clinically identical with other two 
muscular dystrophies caused by LMNA mutations (Fenichel et al., 1982; Miller et al., 
1985; Wehnert and Muntoni, 1999). In addition, the NE localization of emerin largely 
depends on lamin A. The protein is mislocalized to the ER and functionally lost from 
the NE with LMNA mutations (Broers et al., 2006; Worman and Bonne, 2007). My 
study in chapter 2 also reinforced the connection between lamin A and emerin and 
their roles in regulating muscle- and heart-specific gene expression. LAP2α is another 
lamin A interacting protein. A mutation in LAP2α is known to cause dilated 
cardiomyopathy by disrupting its binding to lamin A (Taylor et al., 2005). In addition 
to the aforementioned interactions, lamin A interacts with many proteins, which may 
participate in chromosomal organization, nucleus assembly, transcription, replication, 




it can be assumed that these proteins might also explain the tissue-specific symptoms 
caused by lamin A mutations. Therefore, further exploration of this understudied area 
may lead to improved and potentially therapeutic understanding of many human 
genetic diseases. 
 In chapter 3, I compared the relative stability among several lamin proteins. 
However the mechanisms of degradation of lamin proteins during interphase largely 
remain unknown. The ubiquitin–proteasome and autophagy–lysosome pathways are 
the two main routes of protein and organelle clearance in eukaryotic cells 
(Rubinsztein, 2006). Ubiquitin can be attached to another ubiquitin, creating a ‘chain’ 
that marks the target for proteolytic degradation. By contrast, attachment of a single 
ubiquitin can influence target proteins in diverse ways and regulates many specific 
cellular pathways and nuclear functions (Simon and Wilson, 2013). There are 
widespread ubiquitylation signals of human A- and B-type lamins that have been 
revealed by high-throughput mass spectrometry analysis (Kim et al., 2011b; Wagner 
et al., 2011). Moreover, lamins are directly cleaved by caspases 1 and 6, granzymes A 
and B and CRNSP (Ca+2-regulated nuclear scaffold protease) at sites located near 
many ubiquitylation sites during apoptosis (Clawson et al., 1992; Simon and Wilson, 
2013; Takahashi et al., 1996; Zhang et al., 2001). Yet it is still unclear whether 
polyubiquitination is involved in lamins degradation. Recently, an autophagy-
mediated degradation of lamin B1 has been reported, in which the autophagy protein 
LC3 interacts with lamin B1 and mediates its degradation upon oncogenic insults 




et al., 2015). However, this mechanism is under the condition of oncogenesis. 
Whether it is applicable to more generalized situation remains to be determined.  
 Finally, the regulation of lamin A during differentiation and development is 
understudied. The proximal promoter of LMNA gene is the most well-investigated 
region. However, previous studies showed that it is not responsible for the cell-type-
specific expression of lamin A. The 5’ dismal promoter region, the 3’ UTR area and 
the first intron of LMNA are the proposed candidate regions that may participate in 
lamin A regulation. Although a microRNA, miR9, was identified to target to LMNA 
3’UTR and facilitate the mRNA degradation in brain cells, it is possible that there are 
other tissue-microRNAs functions in other cell types. Moreover, based on high 
conservatory of LMNA first intron, more intensive studies are required to explore its 
role on lamin A regulation. Questions like whether these highly conserved regions 
identified in my study have different regulatory activity in different cell types under 
various differentiation states, what is the function of the actively transcribed regions 
on the antisense strand of LMNA first intron showed by GRO-seq, how do E2F1 and 
HDAC2 repress lamin A expression and do they form repressive complexes with Sp1 
at Con5 region need to be further studied. Furthermore, the potential of the 5’ dismal 






















6.1 Plasmid construction  
 In chapter 2, plasmids of pEGFP-C1-LAΔNLS, pEGFP-C1-PGΔNLS, 
pEGFP-C1-LASSIMΔNLS, and pEGFP-C1-PGSSIMΔNLS were constructed based 
on the pEGFP-C1 vector (Clontech). The NLS sequence 
(AAAAAGCGCAAACTGGAG) was removed from cDNA of Lamin A (LA), 
progerin (PG), LA-SSIM and PG-SSIM by PCR splicing. Primers used were two 
targeting each ends of LMNA, LMNA 5F (5’-AGACCCCGTCCCAGCGGCGCGC-
3’) and LMNA 3R (5’-GTCGACTCTAGATTACATGATGCTGCAGTTCTG-3’), 
and two flanking NLS regions complementary each other, LMNA 5R (5’-
TGCGGCTCTCAGTGGAGGTGACGCTGCCC-3’) and LMNA 3F (5’-
GGGCAGCGTCACCTCCACTGAGAGCCGCA-3’). The 5’- and 3’- regions of 
LMNA were amplified using primer pairs “LMNA 5F + LMNA 5R” and “LMNA 3F 
+ LMNA 3R” respectively, followed by a second amplification using the overlapping 
5’- and 3’- fragments as templates to generate NLS-deleted sequences. The NLS 
deleted sequences were then sub-cloned into the AscI and XbaI sites of pEGFP-C1. A 
plasmid of pDsRed-monomer-C1-LA was created based on the pDsRed-monomer-C1 
vector (Clontech). The full length of lamin A, progerin, LAΔNLS or PGΔNLS was 
amplified using LMNA 5F and LMNA 3R, followed by sub-cloning into the BspEI 
and BamHI sites of pDsRed-monomer-C1. In chapter 3, the lentiviral vector pHR-
SIN-CSGW dlNotI was obtained as previously described (Xiong et al., 2016). Briefly, 
Rluc-P2A in pRP-M-Rluc-P2A-GFP plasmid and EGFP-lamins in above mentioned 
lamin plasmids were amplified by PCR using primer sets P1 (5’-
GGTCCAGCGGATCCATGGCTTCCAAGGTG-3’) and P2 (5’-




P3 (5’-GAGAACCCAGGTCCGATGGTGAGCAAGGGC-3’) and P4 (for LA/PG: 
5’-GGTAGCCTGCGGCCGCAGATTACATGATGCTGCAGTTCTGG-3’, for LB1: 
5’-GGTAGCCTGCGGCCGCTTACATAATTGCACAGCTTCTATTGG-3’), 
targeting EGFP-lamins. The primer P2 completely overlapped with P3, which 
allowed the fragments of Rluc-P2A and EGFP-lamins to automatically ligate together 
in a second round of PCR reaction using P1 and P4. The ligated large fragments were 
subsequently sub-cloned into the BamHI and NotI sites of pHR-SIN-CSGW dlNotI. 
In chapter 4, plasmids of pN3-Sp1FL and pMax-E2F1 were purchased from 
Addgene; pEGFP-C1-HDAC2 was purchased from MRC PPU Reagents and 
Services. Sp1 cDNA was amplified by 4 consecutive PCR using primer pairs in order 
to add a linker between the sequence of EGFP and SP1: 5’- 
CTGAAGAGGACATGAGCGACCAAGATC-3’ and 5’- 
GTTATCTAGATCCTCAGAAGCCATTGC-3’ for the 1st PCR; 5’-
GCAAAAGCTCATTTCTGAAGAGGACATG-3’ and 5’- 
GTTATCTAGATCCTCAGAAGCCATTGC-3’ for the 2nd PCR; 5’-
GACTCAGATCCATGGAGCAAAAGCTC-3’ and 5’- 
GTTATCTAGATCCTCAGAAGCCATTGC-3’ for the 3rd PCR; 5’-
AGCTGTACAAGTCCGGACTCAGATCC-3’ and 5’- 
GTTATCTAGATCCTCAGAAGCCATTGC-3’ for the 4th PCR. The final amplified 
product was subcloned into the BsrGI and XbaI sites of pEGFP-C1. The Renilla 
luciferase reporter vector pGL4.74[hRluc/TK] was purchased from Promega. The 




pGL4.23 GW Reverse vector using pCR™8/GW/TOPO® TA Cloning® Kit 
(Invitrogen) according to the manufacture’s instruction. 
 The sequences of the five conserved regions in LMNA first intron are listed below: 
 
6.2 Cell culture and FTI treatment 
 HeLa cells were cultured in DMEM (Lonza) containing 10% heat-inactivated 
FBS (BenchMark) at 37°C supplied with 5% CO2.  HL60 cells were maintained in 
RPMI-1640 medium (ATCC® 30-2001™) containing 10% FBS supplied with 5% 
CO2.  Human primary skin fibroblasts were obtained from the Progeria Research 
Foundation and cultured in MEM (Life Technologies) supplemented with 20% FBS 

























(Gemini Bio-Products) and 2 mm l-glutamine (Life Technologies) at 37 °C supplied 
with 5% CO2. Human bone marrow mesenchymal stem cells (hBM-MSCs) purchased 
from Rooster Bio were maintained in aMEM (Corning) supplemented with 10% heat-
inactivated FBS (Seradigrn), 2 mm l-glutamine and 1% MEM non-essential amino 
acid (NEAA) (Life Technologies) in 5% CO2 at 37 °C. Control and lamin A null 
mouse embryonic fibroblasts were kindly provided by Dr. Jan Lammerding and 
grown in DMEM (Lonza) supplemented with 10% FBS. In the FTI treatment 
experiment, FTI (J&J) at a final concentration of 2 μM was added to culture media. 
In chapter 2, it was added to culture media 7 hours after transfection for a total of 24 
hours. In chapter 3, it was added at the time of viral infection for a time period of 6 
days. Medium was changed every other day with Lonafarnib supplementation. 
 
6.3 Plasmid and siRNA transfection 
 HeLa cells were transiently transfected using FuGENE® 6 Transfection 
Reagent (Promega) following the manufacturer’s instructions. In chapter 2, 
approximately 1.5×105 cells were seeded and incubated at 37°C for one day, then 
transfected with 2µg of the designated plasmids. For the luciferase activity assay in 
chapter 4, around 2.5×104 cells were seeded and transfected with 0.5µg experimental 
plasmid and 0.2µg pGL4.74 internal control plasmid. Cell were incubated at 37°C for 
two day prior to the luciferase activity assay. HL60 cells were transfected by 
NucleofactorTM 2b machine (Lonza) using Cell Line Nucleofector® Kit V (Lonza) 
according to the manufacturer’s instructions. Briefly, 2×106 cells were transfected 




with fresh medium every other day afterwards. Transfection on primary skin 
fibroblasts were accomplished by using Lipofectamine® 2000 reagent (ThermoFisher 
Scientific). Cells were transfected with 1.6µg of plasmids at 70-90% confluency in 
growth medium. Fresh medium was added the next day. 
 
6.4 Virus generation and viral infection 
 HEK293T cells were co-transfected with lentiviral plasmids and two virus 
packaging vectors, pHR-CMV-8.2ΔR and pCMV-VSVG, utilizing Fugene 6 
(Promega). Culture supernatants were collected on 48 hrs and 72 hrs post- 
transfection, and filtered through 0.45-µm filters to remove any nonadherent 293T 
cells, followed by concentration at 25k RPM for 2 hours in 4°C by OptimaTM L-
100K Ultracentrifuge (Beckman Coulter). The virus pellets were re-suspended in 1 ml 
of cold DMEM/F12 (Lonza), then stored at −80 °C. Next, fibroblasts, hBM-MSCs, 
MEFs or iPSCs were infected by lentiviruses in media supplemented with Polybrene 
(Santa Cruze Biotechnology) with the final concentration of 8 µg/ml. The medium 
was changed every other day post-infection until the cells were harvested.  
 
6.5 Antibodies 
 The antibodies used in Western blotting analysis, immunofluorescence and 
immunoprecipitation were: mouse-anti-human Lamin A/C (MAB3211, Millipore), 
goat-anti-Lamin A/C (N-18, Santa Cruz Biotechnology), goat- anti-Lamin B (sc-




Sigma), mouse-anti-KDEL (ab12223, Abcam), mouse anti-GM130 (610822, BD 
Transduction Laboratories), rabbit-anti-emerin (ab14208-20, Abcam), mouse-anti-γ-
tubulin (019K4794, Sigma), rabbit-anti-GFP antibody (ab290, Abcam), mouse-anti-
Renilla Luciferase Antibody (MAB4410, Millipore), goat-anti-Sp1 (sc-59 X, Santa 
Cruz Biotechnology), E2F1 (05-379, Millipore), HDAC2 (ab12169, Abcam). 
 
6.6 Western Blotting   
 Cell pellets were dissolved in Laemmli Sample Buffer containing 5% β-
mercaptoethanol (Bio-Rad) to obtain whole cell lysates. Protein samples were then 
electrophoretically resolved on 10% SDS-PAGE gels and subsequently transferred 
onto nitrocellulose membranes (Bio-Rad) for primary and secondary antibodies 
detection. Bands were visualized by enhanced chemiluminescence (In chapter 2: 
Pierce® ECL Western Blotting Substrate, Thermo SCIENTIFIC; In chapter 3 and 4: 
ClarityTM Western ECL Substrate, Bio-Rad).  Quantification was performed by 
ImageJ in chapter 2 (National Institutes of Health, Bethesda, Maryland, USA) or 
Image Lab™ Software in chapter 3 and 4 (Bio-Rad). 
 
6.7 Immunofluorescence staining and microscopy  
 Cells were washed twice with tris-buffered saline (TBS) and fixed in 4% 
paraformaldehyde/phosphate buffered saline (PBS) for 20 min at room temperature. 
Subsequently, the cells were permeabilized with 0.5% Triton X-100 in PBS for 5 min 




BSA/TBS for 1 hour, and probed with the primary antibodies overnight at 4°C. The 
cells were then washed five times with TBS, followed by secondary antibody 
incubation at room temperature for 1 hour in the dark. Secondary antibodies used 
were Alexa Fluor® 594 donkey anti-rabbit IgG (Invitrogen), Alexa Fluor® 594 
donkey anti-goat IgG (Invitrogen) and Alexa Fluor® 594 donkey anti-mouse IgG 
(Invitrogen). After being washed five times with TBS, the cells were stained with 
DAPI and mounted using VECTASHIELD® Mounting Medium with DAPI (H-1200, 
VECTOR). Immunofluorescence microscopy was performed on a Leica SP5 X 
Confocal Microscope (Leica Microsystems, Inc., Wetzlar, Germany). 
 
6.8 Immunoprecipitation 
 At 24 hours after transfection, the transfected HeLa cell pellets were lysed in 
ice-cold 1% Triton buffer (1% Triton, 50mM Tirs pH 7.4, 150mM NaCl, 5mM 
MgCl2, 1 X protease inhibitor cocktail (Roche)), and then centrifuged at 2700g at 
4°C for 10 minutes to obtain supernatants. EGFP-tagged proteins were 
immunoprecipitated from the supernatants with GFP-Trap®A beads (Chromoteck) 
according to manufacturer’s instructions. Both input supernatants and 
immunoprecipitates were then resolved on 10% SDS-PAGE gels and subsequently 





6.9 Click chemistry assay 
 HeLa cells transfected with designated pEGFP-C1 based plasmids were 
incubated with Click-iT farnesyl alcohol azide (C10248, Invitrogen) for 14 hours for 
labeling. Cell lysates were collected and immunoprecipitated using GFP-Trap®_A 
beads (Chromotek) according to the manufacturer’s instructions, followed by farnesyl 
detection using Alexa Fluor® 647, alkyne (A10278, Invitrogen). Protein samples 
were then separated with non-reducing 10% SDS-PAGE gels. After being fixed with 
methanol/acetic acid, the SDS-PAGE gels were scanned under a Typhoon imager. 
 
6.10 Fluorescence recovery after photobleaching (FRAP) assay 
 HeLa cells transfected with designated constructs were grown on glass-bottom 
dishes and cultured at 37°C prior to analysis. Photobleaching experiments were 
performed using a Leica SP5 X Confocal Microscope (Leica Microsystems, Inc., 
Wetzlar, Germany). All procedures were done at 37°C. Confocal images were taken 
every three seconds for the first 40 images and every ten seconds for the next 80 
images. Quantification was conducted using Leica SP5 software. 
 
6.11 RNA extraction, cDNA synthesis, and quantitative RT–PCR 
 Total RNA from various cell lines was extracted with Trizol (Life 
Technologies, Carlsbad, California, United States) and purified using the RNeasy 
Mini kit (Qiagen, USA) according to the manufacturer's instructions. The RNA yield 




total RNA was converted to cDNA using iScript Select cDNA Synthesis kit (BioRad, 
USA). Quantitative RT-PCR was performed in triplicate using SYBR Green 
Supermix (BioRad) on CFX ConnectTM rea-time system (BioRad). 
 
6.12 Chromatin immunoprecipitation (ChIP) 
Primary fibroblasts cells were grown until confluency for a week in 145 mm 
dishes. Protein complexes were then crosslinked by addition of formaldehyde to the 
culture medium to a final concentration of 1% for 10 minutes. The reaction was 
stopped by addition of glycine (final concentration 125µM). Fixed cells were rinsed, 
scraped in PBS, pelleted, and flash frozen in liquid nitrogen. Cell pellets were thawed 
on ice and resuspended in Lysis buffer 1 (50 mM HEPES-KOH, pH 7.5, 140 mM 
NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100, 1x protease 
inhibitors) and rocked for 10 min at 4°C. Cells were spun down (2000 rpm for 2 min 
at 4°C), resuspended in Lysis buffer 2 (10 mM Tris-HCl, pH 8.0, 200 mM NaCl, 1 
mM EDTA, 0.5 mM EGTA, 1x protease inhibitors), and pelleted by centrifugation at 
4°C. Pellets were resuspended in 3 mL Lysis buffer 3 (10 mM Tris-HCl, pH 8.0, 100 
mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% Na-Deoxycholate, 0.5% N 
lauroylsarcosine, 1x protease inhibitors), and sonicated on ice for 6 times 25 seconds 
at 30% amplitude with a microtip attached to a Branson digital sonifier 450. 
Immunoprecipitations (IPs) were performed overnight with 30µg of antibody coupled 
to Dynal Protein G Magnetic Beads (Invitrogen). Beads were then washed with 5 




1.0% NP-40, 0.7% Na-Deoxycholate, 1x protease inhibitors) and once in icecold 
PBS. DNA was eluted in Elution buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 
1.0% SDS) and resuspended in 10mM Tris HCl pH 8. 
 
6.13 Luciferase activity assay 
Luciferase activity of LMNA first intron conserved region was tested using the Dual-
luciferase reporter assay system (Promega, E1910) following the manufacture’s 
instruction. Briefly, cells transfected with luciferase reporter constructs were lysed in 
passive lysis buffer. Total of 20ul of cell lysate was mixed with 100ul LARII, 
followed by firefly luminescence measurement using a SpectraMax® M5 Series 
Multi-Mode Microplate Reade (Molecular Devices). Next, 100ul of Stop & Glo 
Reagent was added to the mixture, followed by the reading of Renilla luminescence. 
The final luciferase activity was calculated as the ratio of firefly luminescence to 
Renilla luminescence. 
 
6.14 Conserved region identification and putative transcription factor binding 
prediction in LMNA first intron 
To narrow down the potential targets, five conserved regions were extracted using 
UCSC genome browser, based on 46 species conservatory data - PhastCons scores. In 
evolution theory, it is reasonable to make the assumption that those significant 




transcription enhancers, playing roles for regulation while bound by some related 
transcription factors. In order to uncover their regulatory functions and related 
binding transcription factor partners, we applied PWM-scan tool to predict putative 
transcription factor candidates and their potential binding sites within the five 
conserved regions. In addition, to provide more confidence for those predictions, we 
removed false positive predictions based on chromatin state information (open 
chromatin based on DNase data) and two histone modification markers (H3K27ac 







Adam, S. a, Butin-Israeli, V., Cleland, M. M., Shimi, T. and Goldman, R. D. 
(2013a). Disruption of lamin B1 and lamin B2 processing and localization by 
farnesyltransferase inhibitors. Nucleus 4, 142–50. 
Adam, S. a, Butin-Israeli, V., Cleland, M. M., Shimi, T. and Goldman, R. D. 
(2013b). Disruption of lamin B1 and lamin B2 processing and localization by 
farnesyltransferase inhibitors. Nucleus 4, 142–50. 
Agrelo, R., Setien, F., Espada, J., Artiga, M. J., Rodriguez, M., Pérez-Rosado, A., 
Sanchez-Aguilera, A., Fraga, M. F., Piris, M. A. and Esteller, M. (2005). 
Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in 
hematologic malignancies, and its association with poor survival in nodal diffuse 
large B-cell lymphoma. J. Clin. Oncol. 23, 3940–7. 
Akter, R., Rivas, D., Geneau, G., Drissi, H. and Duque, G. (2009). Effect of Lamin 
A/C Knockdown on Osteoblast Differentiation and Function. J. Bone Miner. 
Res. 24, 283–293. 
Astejada, M. N., Goto, K., Nagano, A., Ura, S., Noguchi, S., Nonaka, I., Nishino, 
I. and Hayashi, Y. K. (2007). Emerinopathy and laminopathy clinical, 
pathological and molecular features of muscular dystrophy with nuclear 
envelopathy in Japan. Acta Myol.  myopathies cardiomyopathies  Off. J. 
Mediterr. Soc. Myol. 26, 159–64. 
Azizkhan, J. C., Jensen, D. E., Pierce, A. J. and Wade, M. (1993). Transcription 




Eukaryot. Gene Expr. 3, 229–54. 
Barrowman, J., Hamblet, C., George, C. M. and Michaelis, S. (2008). Analysis of 
prelamin A biogenesis reveals the nucleus to be a CaaX processing 
compartment. Mol. Biol. Cell 19, 5398–408. 
Barrowman, J., Hamblet, C., Kane, M. S. and Michaelis, S. (2012). Requirements 
for efficient proteolytic cleavage of prelamin A by ZMPSTE24. PLoS One 7, 
e32120. 
Beck, L. A., Hosick, T. J. and Sinensky, M. (1990). Isoprenylation is required for 
the processing of the lamin A precursor. J. Cell Biol. 110, 1489–99. 
Belmont, A. S., Zhai, Y. and Thilenius, A. (1993). Lamin B distribution and 
association with peripheral chromatin revealed by optical sectioning and electron 
microscopy tomography. J. Cell Biol. 123, 1671–85. 
Benavente, R., Krohne, G. and Franke, W. W. (1985). Cell type-specific 
expression of nuclear lamina proteins during development of Xenopus laevis. 
Cell 41, 177–90. 
Bengtsson, L. and Wilson, K. L. (2004). Multiple and surprising new functions for 
emerin, a nuclear membrane protein. Curr. Opin. Cell Biol. 16, 73–79. 
Bergo, M. O., Gavino, B., Ross, J., Schmidt, W. K., Hong, C., Kendall, L. V, 
Mohr, A., Meta, M., Genant, H., Jiang, Y., et al. (2002). Zmpste24 deficiency 
in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A 
processing defect. Proc. Natl. Acad. Sci. U. S. A. 99, 13049–54. 
Berk, J. M., Maitra, S., Dawdy, A. W., Shabanowitz, J., Hunt, D. F. and Wilson, 




binding to barrier to autointegration factor (BAF) in a chromatin- and lamin B-
enriched &quot;niche&quot;. J. Biol. Chem. 288, 30192–209. 
Bertacchini, J., Beretti, F., Cenni, V., Guida, M., Gibellini, F., Mediani, L., 
Marin, O., Maraldi, N. M., de Pol, A., Lattanzi, G., et al. (2013). The protein 
kinase Akt/PKB regulates both prelamin A degradation and Lmna gene 
expression. FASEB J. 27, 2145–55. 
Bione, S., Maestrini, E., Rivella, S., Mancini, M., Regis, S., Romeo, G. and 
Toniolo, D. (1994). Identification of a novel X-linked gene responsible for 
Emery-Dreifuss muscular dystrophy. Nat. Genet. 8, 323–327. 
BLACK, A. R., BLACK, J. D. and AZIZKHAN-CLIFFORD, A. J. (2001). Sp1 
and Krüppel-Like Factor Family of Transcription Factors in Cell Growth 
Regulation and Cancer. J. South. Afr. Stud. 27, 363–379. 
Blumenberg, M. Transcriptional Regulation of Keratin Gene Expression. 
Bonne, G., Schwartz, K., Barletta, M. R. Di, Varnous, S., Bécane, H.-M., 
Hammouda, E.-H., Merlini, L., Muntoni, F., Greenberg, C. R., Gary, F., et 
al. (1999). Mutations in the gene encoding lamin A/C cause autosomal dominant 
Emery-Dreifuss muscular dystrophy. Nat. Genet. 21, 285–288. 
Boyartchuk, V. L., Ashby, M. N. and Rine, J. (1997). Modulation of Ras and a-
factor function by carboxyl-terminal proteolysis. Science 275, 1796–800. 
Bridger, J. M., Foeger, N., Kill, I. R. and Herrmann, H. (2007). The nuclear 
lamina. Both a structural framework and a platform for genome organization. 
FEBS J. 274, 1354–61. 




Raymond, Y. and Ramaekers, F. C. (1997). A- and B-type lamins are 
differentially expressed in normal human tissues. Histochem. Cell Biol. 107, 
505–17. 
Broers, J. L. V., Ramaekers, F. C. S., Bonne, G., Yaou, R. Ben and Hutchison, C. 
J. (2006). Nuclear Lamins: Laminopathies and Their Role in Premature Ageing. 
Physiol. Rev. 86, 967–1008. 
Brunauer, R. and Kennedy, B. K. (2015). Progeria accelerates adult stem cell 
aging. Science (80-. ). 348,. 
Burke, B. and Stewart, C. L. (2012). The nuclear lamins: flexibility in function. 
Nat. Rev. Mol. Cell Biol. 14,. 
Cao, K., Capell, B. C., Erdos, M. R., Djabali, K. and Collins, F. S. (2007). A 
lamin A protein isoform overexpressed in Hutchinson-Gilford progeria 
syndrome interferes with mitosis in progeria and normal cells. Proc. Natl. Acad. 
Sci. U. S. A. 104, 4949–54. 
Cao, K., Blair, C. D., Faddah, D. A., Kieckhaefer, J. E., Olive, M., Erdos, M. R., 
Nabel, E. G. and Collins, F. S. (2011a). Progerin and telomere dysfunction 
collaborate to trigger cellular senescence in normal human fibroblasts. 121,. 
Cao, K., Graziotto, J. J., Blair, C. D., Mazzulli, J. R., Erdos, M. R., Krainc, D. 
and Collins, F. S. (2011b). Rapamycin reverses cellular phenotypes and 
enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome 
cells. Sci. Transl. Med. 3, 89ra58. 
Capell, B. C. and Collins, F. S. (2006). Human laminopathies: nuclei gone 




Capell, B. C., Erdos, M. R., Madigan, J. P., Fiordalisi, J. J., Varga, R., Conneely, 
K. N., Gordon, L. B., Der, C. J., Cox, A. D. and Collins, F. S. (2005). 
Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing 
of Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. U. S. A. 102, 
12879–84. 
Capell, B. C., Olive, M., Erdos, M. R., Cao, K., Faddah, D. a, Tavarez, U. L., 
Conneely, K. N., Qu, X., San, H., Ganesh, S. K., et al. (2008). A 
farnesyltransferase inhibitor prevents both the onset and late progression of 
cardiovascular disease in a progeria mouse model. Proc. Natl. Acad. Sci. U. S. A. 
105, 15902–7. 
Chong, J. A., Tapia-Ramírez, J., Kim, S., Toledo-Aral, J. J., Zheng, Y., Boutros, 
M. C., Altshuller, Y. M., Frohman, M. A., Kraner, S. D. and Mandel, G. 
(1995). REST: a mammalian silencer protein that restricts sodium channel gene 
expression to neurons. Cell 80, 949–57. 
Clawson, G. A., Norbeck, L. L., Hatem, C. L., Rhodes, C., Amiri, P., McKerrow, 
J. H., Patierno, S. R. and Fiskum, G. (1992). Ca(2+)-regulated serine protease 
associated with the nuclear scaffold. Cell Growth Differ. 3, 827–38. 
Clements, L., Manilal, S., Love, D. R. and Morris, G. E. (2000). Direct Interaction 
between Emerin and Lamin A. Biochem. Biophys. Res. Commun. 267, 709–714. 
Columbaro, M., Capanni, C., Mattioli, E., Novelli, G., Parnaik, V. K., Squarzoni, 
S., Maraldi, N. M. and Lattanzi, G. (2005). Rescue of heterochromatin 
organization in Hutchinson-Gilford progeria by drug treatment. Cell. Mol. Life 




CORRIGAN, D. P., KUSZCZAK, D., RUSINOL, A. E., THEWKE, D. P., 
HRYCYNA, C. A., MICHAELIS, S. and SINENSKY, M. S. (2005). Prelamin 
A endoproteolytic processing in vitro by recombinant Zmpste24. Biochem. J. 
387, 129–138. 
Coulson, J. M. (2005). Transcriptional Regulation: Cancer, Neurons and the REST. 
Curr. Biol. 15, R665–R668. 
Croft, J. A., Bridger, J. M., Boyle, S., Perry, P., Teague, P. and Bickmore, W. A. 
(1999). Differences in the localization and morphology of chromosomes in the 
human nucleus. J. Cell Biol. 145, 1119–31. 
Csoka, A. B., English, S. B., Simkevich, C. P., Ginzinger, D. G., Butte, A. J., 
Schatten, G. P., Rothman, F. G. and Sedivy, J. M. (2004). Genome-scale 
expression profiling of Hutchinson-Gilford progeria syndrome reveals 
widespread transcriptional misregulation leading to mesodermal/mesenchymal 
defects and accelerated atherosclerosis. Aging Cell 3, 235–243. 
D’Apice, M. R., Tenconi, R., Mammi, I., van den Ende, J. and Novelli, G. (2004). 
Paternal origin of LMNA mutations in Hutchinson-Gilford progeria. Clin. Genet. 
65, 52–4. 
Dai, Q., Choy, E., Chiu, V., Romano, J., Slivka, S. R., Steitz, S. A., Michaelis, S. 
and Philips, M. R. (1998). Mammalian prenylcysteine carboxyl 
methyltransferase is in the endoplasmic reticulum. J. Biol. Chem. 273, 15030–4. 
de Felipe, P., Luke, G. A., Brown, J. D. and Ryan, M. D. (2010). Inhibition of 2A-
mediated “cleavage” of certain artificial polyproteins bearing N-terminal signal 




De Felipe, P., Luke, G. A., Hughes, L. E., Gani, D., Halpin, C. and Ryan, M. D. 
(2006). E unum pluribus: Multiple proteins from a self-processing polyprotein. 
Trends Biotechnol. 24, 68–75. 
De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., 
Boccaccio, I., Lyonnet, S., Stewart, C. L., Munnich, A., Le Merrer, M., et al. 
(2003). Lamin a truncation in Hutchinson-Gilford progeria. Science 300, 2055. 
Dechat, T., Shimi, T., Adam, S. A., Rusinol, A. E., Andres, D. A., Spielmann, H. 
P., Sinensky, M. S. and Goldman, R. D. (2007). Alterations in mitosis and cell 
cycle progression caused by a mutant lamin A known to accelerate human aging. 
Proc. Natl. Acad. Sci. U. S. A. 104, 4955–60. 
Dechat, T., Pfleghaar, K., Sengupta, K., Shimi, T., Shumaker, D. K., Solimando, 
L. and Goldman, R. D. (2008). Nuclear lamins: major factors in the structural 
organization and function of the nucleus and chromatin. Genes Dev. 22, 832–53. 
Dechat, T., Adam, S. A., Taimen, P., Shimi, T. and Goldman, R. D. (2010). 
Nuclear lamins. Cold Spring Harb. Perspect. Biol. 2, a000547. 
Delbarre, E., Tramier, M., Coppey-Moisan, M., Gaillard, C., Courvalin, J.-C. 
and Buendia, B. (2006). The truncated prelamin A in Hutchinson-Gilford 
progeria syndrome alters segregation of A-type and B-type lamin 
homopolymers. Hum. Mol. Genet. 15, 1113–1122. 
Dittmer, T. A. and Misteli, T. (2011). The lamin protein family. Genome Biol. 12, 
222. 
Doetzlhofer, A., Rotheneder, H., Lagger, G., Koranda, M., Kurtev, V., Brosch, 




Repress Transcription by Binding to Sp1. Mol. Cell. Biol. 19, 5504–5511. 
Donnelly, M. L., Luke, G., Mehrotra, A., Li, X., Hughes, L. E., Gani, D. and 
Ryan, M. D. (2001). Analysis of the aphthovirus 2A/2B polyprotein “cleavage” 
mechanism indicates not a proteolytic reaction, but a novel translational effect: a 
putative ribosomal “skip”. J. Gen. Virol. 82, 1013–25. 
Dou, Z., Xu, C., Donahue, G., Shimi, T., Pan, J.-A., Zhu, J., Ivanov, A., Capell, 
B. C., Drake, A. M., Shah, P. P., et al. (2015). Autophagy mediates 
degradation of nuclear lamina. Nature 527, 1–17. 
Dreuillet, C., Tillit, J., Kress, M. and Ernoult-Lange, M. (2002). In vivo and in 
vitro interaction between human transcription factor MOK2 and nuclear lamin 
A/C. Nucleic Acids Res. 30, 4634–42. 
Eggert, M., Radomski, N., Tripier=, D., Traub, P. and Jost, E. (1991). 
Identification of phosphorylation sites on murine nuclear lamin C by RP-HPLC 
and microsequencing. 292, 205–209. 
Ehninger, D., Neff, F. and Xie, K. (2014). Longevity, aging and rapamycin. Cell. 
Mol. Life Sci. 71, 4325–46. 
Ellis, D. J., Jenkins, H., Whitfield, W. G. and Hutchison, C. J. (1997). GST-lamin 
fusion proteins act as dominant negative mutants in Xenopus egg extract and 
reveal the function of the lamina in DNA replication. J. Cell Sci. 110,. 
Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., 
Erdos, M. R., Robbins, C. M., Moses, T. Y., Berglund, P., et al. (2003). 
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford 




Eriksson, J. E., Dechat, T., Grin, B., Helfand, B., Mendez, M., Pallari, H.-M. and 
Goldman, R. D. (2009). Introducing intermediate filaments: from discovery to 
disease. J. Clin. Invest. 119, 1763–71. 
Espada, J., Varela, I., Flores, I., Ugalde, A. P., Cadiñanos, J., Pendás, A. M., 
Stewart, C. L., Tryggvason, K., Blasco, M. A., Freije, J. M. P., et al. (2008). 
Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. 
J. Cell Biol. 181, 27–35. 
Esteller, M. (2002). CpG island hypermethylation and tumor suppressor genes: a 
booming present, a brighter future. Oncogene 21, 5427–5440. 
Fawcett, D. W. (1966). On the occurrence of a fibrous lamina on the inner aspect of 
the nuclear envelope in certain cells of vertebrates. Am. J. Anat. 119, 129–45. 
Fenichel, G. M., Sul, Y. C., Kilroy, A. W. and Blouin, R. (1982). An autosomal-
dominant dystrophy with humeropelvic distribution and cardiomyopathy. 
Neurology 32, 1399–401. 
Fields, A. P. and Thompson, L. J. (1995). The regulation of mitotic nuclear 
envelope breakdown: a role for multiple lamin kinases. Prog. Cell Cycle Res. 1, 
271–86. 
Foisner ’, R. and Gerace, L. (1993). Integral Membrane Proteins of the Nuclear 
Envelope Interact with Lamins and Chromosomes, and Binding Is Modulated by 
Mitotic Phosphorylation. Cell 73, 1267–1279. 
Fong, L. G., Frost, D., Meta, M., Qiao, X., Yang, S. H., Coffinier, C. and Young, 
S. G. (2006). A Protein Farnesyltransferase Inhibitor Ameliorates Disease in a 




Fritzsche, S. and Springer, S. (2014). Pulse-chase analysis for studying protein 
synthesis and maturation. Curr. Protoc. Protein Sci. 78, 30.3.1-23. 
Furukawa, K. and Hotta, Y. (1993). cDNA cloning of a germ cell specific lamin B3 
from mouse spermatocytes and analysis of its function by ectopic expression in 
somatic cells. EMBO J. 12, 97–106. 
Furukawa, K., Inagaki, H. and Hotta, Y. (1994). Identification and cloning of an 
mRNA coding for a germ cell-specific A-type lamin in mice. Exp. Cell Res. 212, 
426–30. 
Gabriel, D., Roedl, D., Gordon, L. B. and Djabali, K. (2015). Sulforaphane 
enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts. Aging 
Cell 14, 78–91. 
Galiová, G., Bártová, E., Raška, I., Krejčí, J. and Kozubek, S. (2008). Chromatin 
changes induced by lamin A/C deficiency and the histone deacetylase inhibitor 
trichostatin A. Eur. J. Cell Biol. 87, 291–303. 
Gelb, M. H., Brunsveld, L., Hrycyna, C. A., Michaelis, S., Tamanoi, F., Van 
Voorhis, W. C. and Waldmann, H. (2006). Therapeutic intervention based on 
protein prenylation and associated modifications. Nat. Chem. Biol. 2, 518–28. 
Gerace, L., Blobel, G., Petersen, D. F., Branton, D. and Jost, E. (1980). The 
nuclear envelope lamina is reversibly depolymerized during mitosis. Cell 19, 
277–87. 
Goldman, A. E., Moir, R. D., Montag-Lowy, M., Stewart, M. and Goldman, R. 
D. (1992). Pathway of incorporation of microinjected lamin A into the nuclear 




Goldman, R. D., Gruenbaum, Y., Moir, R. D., Shumaker, D. K. and Spann, T. P. 
(2002). Nuclear lamins: building blocks of nuclear architecture. Genes Dev. 16, 
533–47. 
Goldman, R. D., Shumaker, D. K., Erdos, M. R., Eriksson, M., Goldman, A. E., 
Gordon, L. B., Gruenbaum, Y., Khuon, S., Mendez, M., Varga, R., et al. 
(2004). Accumulation of mutant lamin A causes progressive changes in nuclear 
architecture in Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. U. 
S. A. 101, 8963–8. 
Gordon, L. B., Kleinman, M. E., Miller, D. T., Neuberg, D. S., Giobbie-hurder, 
A., Correia, A., Quinn, N., Ullrich, N. J., Nazarian, A., Liang, M. G., et al. 
(2012a). Clinical trial of a farnesyltransferase inhibitor in children with 
Hutchinson – Gilford progeria syndrome. 2–7. 
Gordon, L. B., Kleinman, M. E., Miller, D. T., Neuberg, D. S., Giobbie-Hurder, 
A., Gerhard-Herman, M., Smoot, L. B., Gordon, C. M., Cleveland, R., 
Snyder, B. D., et al. (2012b). Clinical trial of a farnesyltransferase inhibitor in 
children with Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. U. 
S. A. 109, 16666–71. 
Gordon, L. B., Rothman, F. G., López-Otín, C. and Misteli, T. (2014a). Progeria: 
A Paradigm for Translational Medicine. Cell 156, 400–407. 
Gordon, L. B., Massaro, J., D’Agostino, R. B., Campbell, S. E., Brazier, J., 
Brown, W. T., Kleinman, M. E. and Kieran, M. W. (2014b). Impact of 
farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome. 




Gordon, L. B., Kleinman, M. E., Massaro, J., D’Agostino, R. B., Shappell, H., 
Gerhard-Herman, M., Smoot, L. B., Gordon, C. M., Cleveland, R. H., 
Nazarian, A., et al. (2016). Clinical Trial of the Protein Farnesylation Inhibitors 
Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-
Gilford Progeria SyndromeClinical Perspective. Circulation 134,. 
GREENBERG, J. R. (1972). High Stability of Messenger RNA in Growing 
Cultured Cells. Nature 240, 102–104. 
Gruenbaum, Y. and Foisner, R. (2014). Lamins: Nuclear Intermediate Filament 
Proteins with Fundamental Functions in Nuclear Mechanics and Genome 
Regulation. Annu. Rev. Biochem. 84, 150306093657004. 
Gruenbaum, Y., Lee, K. K., Liu, J., Cohen, M. and Wilson, K. L. (2002). The 
expression, lamin-dependent localization and RNAi depletion phenotype for 
emerin in C. elegans. J. Cell Sci. 115,. 
Gruenbaum, Y., Goldman, R. D., Meyuhas, R., Mills, E., Margalit, A., Fridkin, 
A., Dayani, Y., Prokocimer, M. and Enosh, A. (2003). The nuclear lamina and 
its functions in the nucleus. Int. Rev. Cytol. 226, 1–62. 
Gruenbaum, Y., Margalit, A., Goldman, R. D., Shumaker, D. K. and Wilson, K. 
L. (2005). The nuclear lamina comes of age. Nat. Rev. Mol. Cell Biol. 6, 21–31. 
Guelen, L., Pagie, L., Brasset, E., Meuleman, W., Faza, M. B., Talhout, W., 
Eussen, B. H., de Klein, A., Wessels, L., de Laat, W., et al. (2008). Domain 
organization of human chromosomes revealed by mapping of nuclear lamina 
interactions. Nature 453, 948–951. 




Activation of the lamin A gene during rat liver development. FEBS Lett. 392, 
137–42. 
Haraguchi, T., Holaska, J. M., Yamane, M., Koujin, T., Hashiguchi, N., Mori, 
C., Wilson, K. L. and Hiraoka, Y. (2004). Emerin binding to Btf, a death-
promoting transcriptional repressor, is disrupted by a missense mutation that 
causes Emery-Dreifuss muscular dystrophy. Eur. J. Biochem. 271, 1035–1045. 
Heald, R. and McKeon, F. (1990). Mutations of phosphorylation sites in lamin A 
that prevent nuclear lamina disassembly in mitosis. Cell 61, 579–89. 
Hegele, R. A., Cao, H., Liu, D. M., Costain, G. A., Charlton-Menys, V., Rodger, 
N. W. and Durrington, P. N. (2006). Sequencing of the reannotated LMNB2 
gene reveals novel mutations in patients with acquired partial lipodystrophy. Am. 
J. Hum. Genet. 79, 383–9. 
Hennekes, H. and Nigg, E. A. (1994). The role of isoprenylation in membrane 
attachment of nuclear lamins. A single point mutation prevents proteolytic 
cleavage of the lamin A precursor and confers membrane binding properties. J. 
Cell Sci. 107,. 
Herman, J. G. and Baylin, S. B. (2003). Gene Silencing in Cancer in Association 
with Promoter Hypermethylation. N. Engl. J. Med. 349, 2042–2054. 
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I. and Weinberg, R. 
A. (1992). Regulation of Retinoblastoma Protein Functions by Ectopic 
Expression of Human Cyclins. Cell 70, 993–1006. 
Ho, C. Y. and Lammerding, J. (2012). Lamins at a glance. J. Cell Sci. 125,. 




A/C and emerin regulate MKL1–SRF activity by modulating actin dynamics. 
Nature 497, 507–511. 
Holaska, J. M. and Wilson, K. L. (2006). Multiple roles for emerin: implications for 
Emery-Dreifuss muscular dystrophy. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 
288, 676–80. 
Holaska, J. M., Lee, K. K., Kowalski, A. K. and Wilson, K. L. (2002). 
Transcriptional Repressor Germ Cell-less (GCL) and Barrier to Autointegration 
Factor (BAF) Compete for Binding to Emerin in Vitro*. 
Holtz, D., Tanaka, R. A., Hartwig, J. and McKeon, F. (1989). The CaaX motif of 
lamin A functions in conjunction with the nuclear localization signal to target 
assembly to the nuclear envelope. Cell 59, 969–977. 
Hutchison, C. J. (2002). Lamins: building blocks or regulators of gene expression? 
Nat. Rev. Mol. Cell Biol. 3, 848–858. 
Janaki Ramaiah, M. and Parnaik, V. K. (2006). An essential GT motif in the lamin 
A promoter mediates activation by CREB-binding protein. Biochem. Biophys. 
Res. Commun. 348, 1132–1137. 
Jung, H.-J., Coffinier, C., Choe, Y., Beigneux, A. P., Davies, B. S. J., Yang, S. H., 
Barnes, R. H., Hong, J., Sun, T., Pleasure, S. J., et al. (2012). Regulation of 
prelamin A but not lamin C by miR-9, a brain-specific microRNA. Proc. Natl. 
Acad. Sci. U. S. A. 109, E423-31. 
Kang, H. T., Park, J. T., Choi, K., Choi, H. J. C., Jung, C. W., Kim, G. R., Lee, 
Y.-S. and Park, S. C. (2017). Chemical screening identifies ROCK as a target 




Aging Cell 16, 541–550. 
Kaufmann, S. H. (1992). Expression of Nuclear Envelope Lamins A and C in 
Human Myeloid Leukemias1. CANCER Res. 52, 2847–2853. 
Khalifa, M. M. (1989). Hutchinson-Gilford progeria syndrome: report of a Libyan 
family and evidence of autosomal recessive inheritance. Clin. Genet. 35, 125–
32. 
Kim, J. H., Lee, S. R., Li, L. H., Park, H. J., Park, J. H., Lee, K. Y., Kim, M. K., 
Shin, B. A. and Choi, S. Y. (2011a). High cleavage efficiency of a 2A peptide 
derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. 
PLoS One 6, 1–8. 
Kim, W., Bennett, E. J., Huttlin, E. L., Guo, A., Li, J., Possemato, A., Sowa, M. 
E., Rad, R., Rush, J., Comb, M. J., et al. (2011b). Systematic and Quantitative 
Assessment of the Ubiquitin-Modified Proteome. Mol. Cell 44, 325–340. 
Kim, Y. C., Guan, K.-L., Yuan, J., Pollak, M., Sonenberg, N. and Ohsumi, Y. 
(2015). mTOR: a pharmacologic target for autophagy regulation. J. Clin. Invest. 
125, 25–32. 
Kreienkamp, R., Croke, M., Neumann, M. A., Bedia-Diaz, G., Graziano, S., 
Dusso, A., Dorsett, D., Carlberg, C. and Gonzalo, S. (2014). Vitamin D 
receptor signaling improves Hutchinson-Gilford progeria syndrome cellular 
phenotypes. Oncotarget 7, 30018–31. 
Krimm, I., Ostlund, C., Gilquin, B., Couprie, J., Hossenlopp, P., Mornon, J.-P., 
Bonne, G., Courvalin, J.-C., Worman, H. J. and Zinn-Justin, S. (2002). The 




dystrophies, cardiomyopathy, and partial lipodystrophy. Structure 10, 811–23. 
Krohne, G., Benavente, R., Scheer, U. and Dabauvalle, M. C. (2005). The nuclear 
lamina in Heidelberg and W??rzburg: A personal view. Eur. J. Cell Biol. 84, 
163–179. 
Kubben, N., Voncken, J. W., Demmers, J., Calis, C., van Almen, G., Pinto, Y. 
and Misteli, T. (2010). Identification of differential protein interactors of lamin 
A and progerin. Nucleus 1, 513–25. 
Kubben, N., Brimacombe, K. R., Donegan, M., Li, Z. and Misteli, T. (2016). A 
high-content imaging-based screening pipeline for the systematic identification 
of anti-progeroid compounds. Methods 96, 46–58. 
Kudlow, B. A., Kennedy, B. K. and Monnat, R. J. (2007). Werner and Hutchinson-
Gilford progeria syndromes: mechanistic basis of human progeroid diseases. 
Nat. Rev. Mol. Cell Biol. 8, 394–404. 
Kumaran, R. I. and Spector, D. L. (2008). A genetic locus targeted to the nuclear 
periphery in living cells maintains its transcriptional competence. J. Cell Biol. 
180, 51–65. 
Lammerding, J., Schulze, P. C., Takahashi, T., Kozlov, S., Sullivan, T., Kamm, 
R. D., Stewart, C. L. and Lee, R. T. (2004). Lamin A/C deficiency causes 
defective nuclear mechanics and mechanotransduction. J. Clin. Invest. 113, 370–
8. 
Lanoix, J., Skup, D., Collard, J. F. and Raymond, Y. (1992). Regulation of the 
expression of lamins A and C is post-transcriptional in P19 embryonal 




Lattanzi, G., Marmiroli, S., Facchini, A. and Maraldi, N. M. (2012). Nuclear 
damages and oxidative stress: new perspectives for laminopathies. Eur. J. 
Histochem. 56, e45. 
Lazebnik, Y. A., Takahashi, A., Moir, R. D., Goldman, R. D., Poirier, G. G., 
Kaufmann, S. H. and Earnshaw, W. C. (1995). Studies of the lamin proteinase 
reveal multiple parallel biochemical pathways during apoptotic execution. Proc. 
Natl. Acad. Sci. U. S. A. 92, 9042–6. 
Lebel, S., Lampron, C., Royal, A. and Raymond, Y. (1987). Lamins A and C 
appear during retinoic acid-induced differentiation of mouse embryonal 
carcinoma cells. J. Cell Biol. 105, 1099–104. 
Lee, K. K., Haraguchi, T., Lee, R. S., Koujin, T., Hiraoka, Y. and Wilson, K. L. 
(2001). Distinct functional domains in emerin bind lamin A and DNA-bridging 
protein BAF. J. Cell Sci. 114, 4567–73. 
Lehner, C. F., Fürstenberger, G., Eppenberger, H. M. and Nigg, E. A. (1986). 
Biogenesis of the nuclear lamina: in vivo synthesis and processing of nuclear 
protein precursors. Proc. Natl. Acad. Sci. U. S. A. 83, 2096–9. 
Lehner, C. F., Stick, R., Eppenberger, H. M. and Nigg, E. A. (1987). Differential 
expression of nuclear lamin proteins during chicken development. J. Cell Biol. 
105, 577–87. 
Li, L. and Davie, J. R. (2010). The role of Sp1 and Sp3 in normal and cancer cell 
biology. Ann. Anat. - Anat. Anzeiger 192, 275–283. 
Lin, F. and Worman, H. J. (1993). Structural organization of the human gene 




Lin, F. and Worman, H. J. (1997). Expression of nuclear lamins in human tissues 
and cancer cell lines and transcription from the promoters of the lamin A/C and 
B1 genes. Exp. Cell Res. 236, 378–84. 
Lin, S. Y., Black, A. R., Kostic, D., Pajovic, S., Hoover, C. N. and Azizkhan, J. C. 
(1996). Cell cycle-regulated association of E2F1 and Sp1 is related to their 
functional interaction. Mol. Cell. Biol. 16, 1668–75. 
Lin, F., Blake, D. L., Callebaut, I., Skerjanc, I. S., Holmer, L., McBurney, M. W., 
Paulin-Levasseur, M. and Worman, H. J. (2000). MAN1, an inner nuclear 
membrane protein that shares the LEM domain with lamina-associated 
polypeptide 2 and emerin. J. Biol. Chem. 275, 4840–7. 
Lloyd, D. J., Trembath, R. C. and Shackleton, S. (2002). A novel interaction 
between lamin A and SREBP1: implications for partial lipodystrophy and other 
laminopathies. Hum. Mol. Genet. 11,. 
Lo Cicero, A. and Nissan, X. (2015). Pluripotent stem cells to model Hutchinson-
Gilford progeria syndrome (HGPS): Current trends and future perspectives for 
drug discovery. Ageing Res. Rev. 24, 343–348. 
Lourim, D., Kempf, A. and Krohne, G. (1996). Characterization and quantitation of 
three B-type lamins in Xenopus oocytes and eggs: increase of lamin LI protein 
synthesis during meiotic maturation. J. Cell Sci. 109,. 
Lutz, R. J., Trujillo, M. A., Denham, K. S., Wenger, L. and Sinensky, M. (1992). 
Nucleoplasmic localization of prelamin A: implications for prenylation-
dependent lamin A assembly into the nuclear lamina. Proc. Natl. Acad. Sci. U. S. 




Machiels, B. M., Zorenc, A. H., Endert, J. M., Kuijpers, H. J., van Eys, G. J., 
Ramaekers, F. C. and Broers, J. L. (1996). An alternative splicing product of 
the lamin A/C gene lacks exon 10. J. Biol. Chem. 271, 9249–53. 
Maciel, A. T., Opitz, J. M. and Reynolds, J. F. (1988). Evidence for autosomal 
recessive inheritance of progeria (Hutchinson Gilford). Am. J. Med. Genet. 31, 
483–7. 
Markiewicz, E., Dechat, T., Foisner, R., Quinlan, R. A. and Hutchison, C. J. 
(2002). Lamin A/C binding protein LAP2alpha is required for nuclear anchorage 
of retinoblastoma protein. Mol. Biol. Cell 13, 4401–13. 
Maske, C. P., Hollinshead, M. S., Higbee, N. C., Bergo, M. O., Young, S. G. and 
Vaux, D. J. (2003). A carboxyl-terminal interaction of lamin B1 is dependent on 
the CAAX endoprotease Rce1 and carboxymethylation. J. Cell Biol. 162, 1223–
32. 
Mattia, E., Hoff, W. D., Blaauwen, J. den, Meijne, A. M. L., Stuurman, N. and 
Renswoude, J. van (1992). Induction of nuclear lamins A/C during in vitro-
induced differentiation of F9 and P19 embryonal carcinoma cells. Exp. Cell Res. 
203, 449–455. 
McCord, R. P., Nazario-Toole, A., Zhang, H., Chines, P. S., Zhan, Y., Erdos, M. 
R., Collins, F. S., Dekker, J. and Cao, K. (2013a). Correlated alterations in 
genome organization, histone methylation, and DNA-lamin A/C interactions in 
Hutchinson-Gilford progeria syndrome. Genome Res. 23, 260–9. 
McCord, R. P., Nazario-Toole, A., Zhang, H., Chines, P. S., Zhan, Y., Erdos, M. 




genome organization, histone methylation, and DNA-lamin A/C interactions in 
Hutchinson-Gilford progeria syndrome. Genome Res. 23, 260–9. 
McKeon, F. D., Kirschner, M. W. and Caput, D. (1986). Homologies in both 
primary and secondary structure between nuclear envelope and intermediate 
filament proteins. Nature 319, 463–8. 
Meier, J., Campbell, K. H., Ford, C. C., Stick, R. and Hutchison, C. J. (1991). 
The role of lamin LIII in nuclear assembly and DNA replication, in cell-free 
extracts of Xenopus eggs. J. Cell Sci. 98,. 
Merideth, M. A., Gordon, L. B., Clauss, S., Sachdev, V., Smith, A. C. M., Perry, 
M. B., Brewer, C. C., Zalewski, C., Kim, H. J., Solomon, B., et al. (2008). 
Phenotype and Course of Hutchinson–Gilford Progeria Syndrome. N. Engl. J. 
Med. 358, 592–604. 
Miller, R. G., Layzer, R. B., Mellenthin, M. A., Golabi, M., Francoz, R. A. and 
Mall, J. C. (1985). Emery-Dreifuss muscular dystrophy with autosomal 
dominant transmission. Neurology 35, 1230–3. 
Mislow, J. M. K., Holaska, J. M., Kim, M. S., Lee, K. K., Segura-Totten, M., 
Wilson, K. L. and McNally, E. M. (2002). Nesprin-1alpha self-associates and 
binds directly to emerin and lamin A in vitro. FEBS Lett. 525, 135–40. 
Moir, R. D., Spann, T. P., Lopez-Soler, R. I., Yoon, M., Goldman, A. E., Khuon, 
S. and Goldman, R. D. (2000). Review: the dynamics of the nuclear lamins 
during the cell cycle-- relationship between structure and function. J. Struct. 
Biol. 129, 324–34. 




A., Grange, D. K., Young, S. G. and Miner, J. H. (2007). Increased progerin 
expression associated with unusual LMNA mutations causes severe progeroid 
syndromes. Hum. Mutat. 28, 882–889. 
Munro, S. and Pelham, H. R. (1987). A C-terminal signal prevents secretion of 
luminal ER proteins. Cell 48, 899–907. 
Muralikrishna, B. and Parnaik, V. K. (2001). SP3 and AP-1 mediate 
transcriptional activation of the lamin A proximal promoter. Eur. J. Biochem. 
268, 3736–43. 
Nakajima, N. and Abe, K. (1995). Genomic structure of the mouse A-type lamin 
gene locus encoding somatic and germ cell-specific lamins. FEBS Lett. 365, 
108–114. 
Nakamachi, K. and Nakajima, N. (2000a). Dnase I hypersensitive sites and 
transcriptional activation of the lamin A/C gene. Eur. J. Biochem. 267, 1416–
1422. 
Nakamachi, K. and Nakajima, N. (2000b). DNase I hypersensitive sites and 
transcriptional activation of the lamin A/C gene. Eur. J. Biochem. 267, 1416–
1422. 
Nakamura, N., Rabouille, C., Watson, R., Nilsson, T., Hui, N., Slusarewicz, P., 
Kreis, T. E. and Warren, G. (1995). Characterization of a cis-Golgi matrix 
protein, GM130. J. Cell Biol. 131, 1715–26. 
Newport, J. W., Wilson, K. L. and Dunphy, W. G. (1990). A lamin-independent 
pathway for nuclear envelope assembly. J. Cell Biol. 111, 2247–59. 




Kesteven, S. H., Michalicek, J., Otway, R., Verheyen, F., et al. (2004). 
Defects in nuclear structure and function promote dilated cardiomyopathy in 
lamin A/C–deficient mice. J. Clin. Invest. 113, 357–369. 
Nili, E., Cojocaru, G. S., Kalma, Y., Ginsberg, D., Copeland, N. G., Gilbert, D. 
J., Jenkins, N. A., Berger, R., Shaklai, S., Amariglio, N., et al. (2001). 
Nuclear membrane protein LAP2β mediates transcriptional repression alone and 
together with its binding partner GCL (germ cell-less). J. Cell Sci. 114,. 
Okumura, K., Hosoe, Y. and Nakajima, N. (2004). c-Jun and Sp1 family are 
critical for retinoic acid induction of the lamin A/C retinoic acid-responsive 
element. Biochem. Biophys. Res. Commun. 320, 487–492. 
Olins, A. L., Herrmann, H., Lichter, P., Kratzmeier, M., Doenecke, D. and Olins, 
D. E. (2001). Nuclear Envelope and Chromatin Compositional Differences 
Comparing Undifferentiated and Retinoic Acid- and Phorbol Ester-Treated HL-
60 Cells. Exp. Cell Res. 268, 115–127. 
Osorio, F. G., Navarro, C. L., Cadiñanos, J., López-Mejía, I. C., Quirós, P. M., 
Bartoli, C., Rivera, J., Tazi, J., Guzmán, G., Varela, I., et al. (2011). 
Splicing-Directed Therapy in a New Mouse Model of Human Accelerated 
Aging. Sci. Transl. Med. 3,. 
Osouda, S., Nakamura, Y., de Saint Phalle, B., McConnell, M., Horigome, T., 
Sugiyama, S., Fisher, P. A. and Furukawa, K. (2005). Null mutants of 
Drosophila B-type lamin Dm0 show aberrant tissue differentiation rather than 
obvious nuclear shape distortion or specific defects during cell proliferation. 




Ostlund, C., Ellenberg, J., Hallberg, E., Lippincott-Schwartz, J. and Worman, 
H. J. (1999). Intracellular trafficking of emerin, the Emery-Dreifuss muscular 
dystrophy protein. J. Cell Sci. 112,. 
Padiath, Q. S., Saigoh, K., Schiffmann, R., Asahara, H., Yamada, T., Koeppen, 
A., Hogan, K., Ptáček, L. J. and Fu, Y.-H. (2006). Lamin B1 duplications 
cause autosomal dominant leukodystrophy. Nat. Genet. 38, 1114–1123. 
Pajerowski, J. D., Dahl, K. N., Zhong, F. L., Sammak, P. J. and Discher, D. E. 
(2007). Physical plasticity of the nucleus in stem cell differentiation. Proc. Natl. 
Acad. Sci. 104, 15619–15624. 
Pankov, R., Neznanov, N., Umezawa, A. and Oshima, R. G. (1994). AP-1, ETS, 
and transcriptional silencers regulate retinoic acid-dependent induction of keratin 
18 in embryonic cells. Mol. Cell. Biol. 14, 7744–57. 
Paradisi, M., McClintock, D., Boguslavsky, R. L., Pedicelli, C., Worman, H. J. 
and Djabali, K. (2005). Dermal fibroblasts in Hutchinson-Gilford progeria 
syndrome with the lamin A G608G mutation have dysmorphic nuclei and are 
hypersensitive to heat stress. BMC Cell Biol. 6, 27. 
Parra, M. K., Gee, S., Mohandas, N. and Conboy, J. G. (2011). Efficient in Vivo 
Manipulation of Alternative Pre-mRNA Splicing Events Using Antisense 
Morpholinos in Mice. J. Biol. Chem. 286, 6033–6039. 
Peter, M., Nakagawa, J., Dotie, M., Labbc, J. C. and Nigg, E. A. (1990). In Vitro 
Disassembly of the Nuclear Lamina and M Phase-Specific Phosphorylation of 
Lamins by cdc2 Kinase. Cell 61, 591–602. 




C. A. (1990). In vitro posttranslational modification of lamin B cloned from a 
human T-cell line. Mol. Cell. Biol. 10, 2164–75. 
Pollex, R. and Hegele, R. (2004). Hutchinson-Gilford progeria syndrome. Clin. 
Genet. 66, 375–381. 
Pugh, B. F. and Tjian, R. (1990). Mechanism of transcriptional activation by Sp1: 
Evidence for coactivators. Cell 61, 1187–1197. 
Rao, L., Perez, D. and White, E. (1996). Lamin proteolysis facilitates nuclear events 
during apoptosis. J. Cell Biol. 135, 1441–55. 
Rauner, M., Sipos, W., Goettsch, C., Wutzl, A., Foisner, R., Pietschmann, P. and 
Hofbauer, L. C. (2009). Inhibition of Lamin A/C Attenuates Osteoblast 
Differentiation and Enhances RANKL-Dependent Osteoclastogenesis. J. Bone 
Miner. Res. 24, 78–86. 
Reunert, J., Wentzell, R., Walter, M., Jakubiczka, S., Zenker, M., Brune, T., 
Rust, S. and Marquardt, T. (2012). Neonatal progeria: increased ratio of 
progerin to lamin A leads to progeria of the newborn. Eur. J. Hum. Genet. 20, 
933. 
Richards, S. A., Muter, J., Ritchie, P., Lattanzi, G. and Hutchison, C. J. (2011). 
The accumulation of un-repairable DNA damage in laminopathy progeria 
fibroblasts is caused by ROS generation and is prevented by treatment with N-
acetyl cysteine. Hum. Mol. Genet. 20, 3997–4004. 
Riemer, D., Stuurman, N., Berrios, M., Hunter, C., Fisher, P. A. and Weber, K. 
(1995). Expression of Drosophila lamin C is developmentally regulated: 




Röber, R. A., Weber, K. and Osborn, M. (1989). Differential timing of nuclear 
lamin A/C expression in the various organs of the mouse embryo and the young 
animal: a developmental study. Development 105, 365–78. 
Rodgers, H. F., Lavranos, T. C., Vella, C. A. and Rodgers, R. J. (1995). Basal 
lamina and other extracellular matrix produced by bovine granulosa cells in 
anchorage-independent culture. Cell Tissue Res. 282, 463–71. 
Rodriguez-Contreras, D., Aslan, H., Feng, X., Tran, K., Yates, P. A., Kamhawi, 
S. and Landfear, S. M. (2015). Regulation and biological function of a flagellar 
glucose transporter in Leishmania mexicana: a potential glucose sensor. FASEB 
J. 29, 11–24. 
Rubinsztein, D. C. (2006). The roles of intracellular protein-degradation pathways in 
neurodegeneration. Nature 443, 780–786. 
Rusiñol, A. E. and Sinensky, M. S. (2006). Farnesylated lamins, progeroid 
syndromes and farnesyl transferase inhibitors. J. Cell Sci. 119,. 
Ryan, M. D., King, A. M. and Thomas, G. P. (1991). Cleavage of foot-and-mouth 
disease virus polyprotein is mediated by residues located within a 19 amino acid 
sequence. J. Gen. Virol. 72 ( Pt 11, 2727–32. 
Sarkar, P. K. and Shinton, R. A. (2001). Hutchinson-Guilford progeria syndrome. 
Postgrad. Med. J. 77, 312–7. 
Sasseville, A. M. and Raymond, Y. (1995). Lamin A precursor is localized to 
intranuclear foci. J. Cell Sci. 273–85. 
Schneider, U., Mini, T., Jenö, P., Fisher, P. A. and Stuurman, N. (1999). 




during Both M-Phase (Meiosis) and Interphase by Electrospray Ionization 
Tandem Mass Spectrometry. Biochemistry 38, 4620–4632. 
Shumaker, D. K., Lopez-Soler, R. I., Adam, S. A., Herrmann, H., Moir, R. D., 
Spann, T. P. and Goldman, R. D. (2005). Functions and dysfunctions of the 
nuclear lamin Ig-fold domain in nuclear assembly, growth, and Emery-Dreifuss 
muscular dystrophy. Proc. Natl. Acad. Sci. U. S. A. 102, 15494–9. 
Shumaker, D. K., Dechat, T., Kohlmaier, A., Adam, S. A., Bozovsky, M. R., 
Erdos, M. R., Eriksson, M., Goldman, A. E., Khuon, S., Collins, F. S., et al. 
(2006). Mutant nuclear lamin A leads to progressive alterations of epigenetic 
control in premature aging. Proc. Natl. Acad. Sci. U. S. A. 103, 8703–8. 
Simon, D. N. and Wilson, K. L. (2013). Partners and post-translational 
modifications of nuclear lamins. Chromosoma 122, 13–31. 
Sinensky, M., Fantle, K., Trujillo, M., McLain, T., Kupfer, A. and Dalton, M. 
(1994). The processing pathway of prelamin A. J. Cell Sci. 107 ( Pt 1, 61–7. 
Spann, T. P., Moir, R. D., Goldman, A. E., Stick, R. and Goldman, R. D. (1997). 
Disruption of Nuclear Lamin Organization Alters the Distribution of Replication 
Factors and Inhibits DNA Synthesis. J. Cell Biol. 136,. 
Spann, T. P., Goldman, A. E., Wang, C., Huang, S. and Goldman, R. D. (2002). 
Alteration of nuclear lamin organization inhibits RNA polymerase II-dependent 
transcription. J. Cell Biol. 156, 603–8. 
Stadelmann, B., Khandjian, E., Hirt, A., Lüthy, A., Weil, R. and Wagner, H. P. 
(1990). Repression of nuclear lamin A and C gene expression in human acute 





Stewart, C. and Burke, B. (1987). Teratocarcinoma stem cells and early mouse 
embryos contain only a single major lamin polypeptide closely resembling lamin 
B. Cell 51, 383–92. 
Stick, R. and Hausen, P. (1985). Changes in the nuclear lamina composition during 
early development of Xenopus laevis. Cell 41, 191–200. 
Stuurman, N., Heins, S. and Aebi, U. (1998). Nuclear Lamins: Their Structure, 
Assembly, and Interactions. J. Struct. Biol. 122, 42–66. 
Sullivan, T., Escalante-Alcalde, D., Bhatt, H., Anver, M., Bhat, N., Nagashima, 
K., Stewart, C. L. and Burke, B. (1999). Loss of A-type lamin expression 
compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell 
Biol. 147, 913–20. 
Suske, G. (1999). The Sp-family of transcription factors. Gene 238, 291–300. 
Takahashi, A., Alnemri, E. S., Lazebnik, Y. A., Fernandes-Alnemri, T., Litwack, 
G., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H. and 
Earnshaw, W. C. (1996). Cleavage of lamin A by Mch2 alpha but not CPP32: 
multiple interleukin 1 beta-converting enzyme-related proteases with distinct 
substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. U. 
S. A. 93, 8395–400. 
Tan, N. Y. and Khachigian, L. M. (2009). Sp1 phosphorylation and its regulation of 
gene transcription. Mol. Cell. Biol. 29, 2483–2488. 
Taylor, M. R. G., Slavov, D., Gajewski, A., Vlcek, S., Ku, L., Fain, P. R., Carniel, 




(lamina-associated polypeptide 2) gene mutation associated with dilated 
cardiomyopathy. Hum. Mutat. 26, 566–574. 
Thompson, L. J. and Fields, A. P. (1996). betaII protein kinase C is required for the 
G2/M phase transition of cell cycle. J. Biol. Chem. 271, 15045–53. 
Thompson, L. J., Bollen, M. and Fields, A. P. (1997). Identification of protein 
phosphatase 1 as a mitotic lamin phosphatase. J. Biol. Chem. 272, 29693–7. 
Tilgner, K., Wojciechowicz, K., Jahoda, C., Hutchison, C. and Markiewicz, E. 
(2009). Dynamic complexes of A-type lamins and emerin influence adipogenic 
capacity of the cell via nucleocytoplasmic distribution of  -catenin. J. Cell Sci. 
122, 401–413. 
Toth, J. I., Yang, S. H., Qiao, X., Beigneux, A. P., Gelb, M. H., Moulson, C. L., 
Miner, J. H., Young, S. G. and Fong, L. G. (2005). Blocking protein 
farnesyltransferase improves nuclear shape in fibroblasts from humans with 
progeroid syndromes. Proc. Natl. Acad. Sci. U. S. A. 102, 12873–8. 
Toyama, B. H., Savas, J. N., Park, S. K., Harris, M. S., Ingolia, N. T., Yates, J. R. 
and Hetzer, M. W. (2013). Identification of long-lived proteins reveals 
exceptional stability of essential cellular structures. Cell 154, 971–82. 
Varela, I., Pereira, S., Ugalde, A. P., Navarro, C. L., Suárez, M. F., Cau, P., 
Cadiñanos, J., Osorio, F. G., Foray, N., Cobo, J., et al. (2008). Combined 
treatment with statins and aminobisphosphonates extends longevity in a mouse 
model of human premature aging. Nat. Med. 14, 767–772. 
Vaughan, A., Alvarez-Reyes, M., Bridger, J. M., Broers, J. L., Ramaekers, F. C., 




Both emerin and lamin C depend on lamin A for localization at the nuclear 
envelope. J. Cell Sci. 114, 2577–90. 
Vergnes, L., Peterfy, M., Bergo, M. O., Young, S. G. and Reue, K. (2004). Lamin 
B1 is required for mouse development and nuclear integrity. Proc. Natl. Acad. 
Sci. 101, 10428–10433. 
Verstraeten, V. L. R. M., Peckham, L. A., Olive, M., Capell, B. C., Collins, F. S., 
Nabel, E. G., Young, S. G., Fong, L. G. and Lammerding, J. (2011). Protein 
farnesylation inhibitors cause donut-shaped cell nuclei attributable to a 
centrosome separation defect. Proc. Natl. Acad. Sci. 108, 4997–5002. 
Vidak, S. and Foisner, R. (2016). Molecular insights into the premature aging 
disease progeria. Histochem. Cell Biol. 145, 401–17. 
Vigouroux, C. and Bonne, G. (2013). Laminopathies: One Gene, Two Proteins, Five 
Diseases.. 
Viteri, G., Chung, Y. W. and Stadtman, E. R. (2010). Effect of progerin on the 
accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford 
progeria patients. Mech. Ageing Dev. 131, 2–8. 
Vizcaíno, C., Mansilla, S. and Portugal, J. (2015). Sp1 transcription factor: A long-
standing target in cancer chemotherapy. Pharmacol. Ther. 152, 111–124. 
Vlcek, S. and Foisner, R. (2007). A-type lamin networks in light of laminopathic 
diseases. Biochim. Biophys. Acta 1773, 661–74. 
Wagner, S. A., Beli, P., Weinert, B. T., Nielsen, M. L., Cox, J., Mann, M. and 
Choudhary, C. (2011). A Proteome-wide, Quantitative Survey of In Vivo 




Proteomics 10, M111.013284-M111.013284. 
Ward, G. E., Kirschner, M. W., McIntosh, J. R., Burnett, J. P., Hermodson, M. 
A., Roach, P. J., Malviya, A. N., Sclafani, R. A., Benton, B. M. and Fisher, P. 
A. (1990). Identification of cell cycle-regulated phosphorylation sites on nuclear 
lamin C. Cell 61, 561–77. 
Wehnert, M. and Muntoni, F. (1999). 60th ENMC International Workshop: non X-
linked Emery-Dreifuss Muscular Dystrophy 5-7 June 1998, Naarden, The 
Netherlands. Neuromuscul. Disord. 9, 115–21. 
Wilson, K. L. and Foisner, R. (2010). Lamin-binding Proteins. Cold Spring Harb. 
Perspect. Biol. 2, a000554. 
Winter-Vann, A. M. and Casey, P. J. (2005). Opinion: Post-prenylation-processing 
enzymes as new targets in oncogenesis. Nat. Rev. Cancer 5, 405–412. 
Wolin, S. L., Krohne, G. and Kirschner, M. W. (1987). A new lamin in Xenopus 
somatic tissues displays strong homology to human lamin A. EMBO J. 6, 3809–
18. 
Won, J., Yim, J. and Kim, T. K. (2002). Sp1 and Sp3 recruit histone deacetylase to 
repress transcription of human telomerase reverse transcriptase (hTERT) 
promoter in normal human somatic cells. J. Biol. Chem. 277, 38230–8. 
Worman, H. J. and Bonne, G. (2007). &quot;Laminopathies&quot;: a wide 
spectrum of human diseases. Exp. Cell Res. 313, 2121–33. 
Wright, L. P. and Philips, M. R. (2006). Thematic review series: lipid 
posttranslational modifications. CAAX modification and membrane targeting of 




Wu, D., Flannery, A. R., Cai, H., Ko, E. and Cao, K. (2014). Nuclear localization 
signal deletion mutants of lamin A and progerin reveal insights into lamin A 
processing and emerin targeting. Nucleus 5, 66–74. 
Wu, D., Yates, P. A., Zhang, H. and Cao, K. (2016). Comparing lamin proteins 
post-translational relative stability using a 2A peptide-based system reveals 
elevated resistance of progerin to cellular degradation. Nucleus 7, 585–596. 
Xiong, Z.-M., Choi, J. Y., Wang, K., Zhang, H., Tariq, Z., Wu, D., Ko, E., 
LaDana, C., Sesaki, H. and Cao, K. (2016). Methylene blue alleviates nuclear 
and mitochondrial abnormalities in progeria. Aging Cell 15, 279–90. 
Yang, S. H., Bergo, M. O., Toth, J. I., Qiao, X., Hu, Y., Sandoval, S., Meta, M., 
Bendale, P., Gelb, M. H., Young, S. G., et al. (2005). Blocking protein 
farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a 
targeted Hutchinson-Gilford progeria syndrome mutation. Proc. Natl. Acad. Sci. 
U. S. A. 102, 10291–6. 
Yang, S. H., Meta, M., Qiao, X., Frost, D., Bauch, J., Coffinier, C., Majumdar, 
S., Bergo, M. O., Young, S. G. and Fong, L. G. (2006). A farnesyltransferase 
inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford 
progeria syndrome mutation. J. Clin. Invest. 116, 2115–21. 
Yang, S. H., Andres, D. A., Spielmann, H. P., Young, S. G. and Fong, L. G. 
(2008). Progerin elicits disease phenotypes of progeria in mice whether or not it 
is farnesylated. J. Clin. Invest. 118, 3291–300. 
Yang, S. H., Chang, S. Y., Ren, S., Wang, Y., Andres, D. A., Spielmann, H. P., 




phenotypes in knock-in mice expressing a non-farnesylated version of progerin. 
Hum. Mol. Genet. 20, 436–44. 
Zhang, D., Beresford, P. J., Greenberg, A. H. and Lieberman, J. (2001). 
Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during 
granule-mediated cytolysis. Proc. Natl. Acad. Sci. 98, 5746–5751. 
Zhang, H., Xiong, Z.-M. and Cao, K. (2014). Mechanisms controlling the smooth 
muscle cell death in progeria via down-regulation of poly(ADP-ribose) 
polymerase 1. Proc. Natl. Acad. Sci. U. S. A. 111, E2261-70. 
Zhou, P. (2004). Determining protein half-lives. Methods Mol. Biol. 284, 67–77. 
 
